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ABSTRACT
Ethnopharmacological relevance: Maca - Lepidium meyenii Walp has been cultivated and used
by Andean people for over 1,300 to 2000 years in Peru as food and medicine. Starting in the
late 1990’s it has developed into an important herbal medicine in China and is now cultivated
there widely, too.
Aim of study: This study aims to provide an insight into the emergence of maca on the global
market as an alternative remedy to treat reproductive health related problems in both men and
women and to critically assess these health claims.
Methodology: A search of electronic databases such as EMBASE and a hand-search was done
to acquire peer-reviewed articles and reports about maca.
Results and discussion: Lepidium meyenii is used traditionally as a tonic, fertility enhancer for
both humans and cattle, and to treat a variety of ailments such as rheumatism, respiratory
disorders and anaemia among others. Maca root is cooked, baked, fermented as a drink and
made into porridge. In the last twenty years, maca was introduced onto the global market and
demand has dramatically grown over this time with its promotion on the internet, as the
‘Peruvian Ginseng’ for libido and fertility enhancement. It has also been said to treat
menopausal symptoms, erectile dysfunction and benign prostatic hyperplasia. The sky-
rocketing demand for the plant has seen a shift from traditional cultivation methods to mass
production practices with the use of fertilisers and also pesticides; as maca is now grown in
areas other than the Andes such as in the Yunnan province in China. This can potentially affect
the phytochemistry and composition of the plant and thus, the quality, safety and efficacy of
maca products. Meanwhile, research into maca’s medicinal properties has followed the spike
in popularity of maca and has been focused mainly on maca’s aphrodisiac and fertility
enhancing properties. So far, the in vivo studies and clinical trials conducted have yielded
inconclusive results. Some of the key limitations reside in methodology and sample size.
Chemical profiling, led to the discovery of new compounds unique to maca, such as,
‘macamides’ and also other active metabolites like the glucosinolates; to which the medicinal
effects of maca have been ascribed but cannot be confirmed due to lack of data.
Conclusions: To date, the health claims of maca cannot be fully supported from a scientific
standpoint and more research is needed. It appears that the indigenous local knowledge about
2the health benefits of maca has been dragged out of context to fit the demands of a growing
market for herbal remedies. This globalisation (or hype esp. in China) also has had serious
consequences for the local producers in Peru. The lack of protocols to regulate the production
and marketing of maca during this rapid expansion, poses a threat to both the safety of
consumers and the sustainability of supply.
Keywords: Maca, Lepidium meyenii, Lepidium peruvianum, Pharmacological activity,
Phytochemistry, Reproductive health
Compounds studied: Imidazole alkaloids (Lepidiline A, Lepidiline B, Lepidiline C,
Lepidiline D and macaridine); Macahydantoins; Macathiohydantoins; Meyeniins; Macamides
(alkamides unique to maca); Glucosinolates; tetrahydro-β -carboline 
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1. INTRODUCTION
Lepidium meyenii (Walpers 1843; cf Chacon 1990), commonly known as maca, is a species indigenous
to the Central Andes of Peru. It has been cultivated traditionally as a food crop and for its medicinal
properties.
Over the last two decades, the interest and demand for maca has grown worldwide through an aggressive
marketing promotion of the plant via the media and internet. This has established maca as one of the
flagship products of Peru. Maca is sold as powder, pills, capsules, flour, liquor and extracts (Gonzales
et al., 2009) and is available from a variety of retail outlets like health food stores and smoothie shops
(Smith, 2014).
Maca has been advertised as a ‘superfood’ and as the ‘Peruvian Viagra’ and the ‘Peruvian Ginseng’
referring to the attributed health claims of increasing vitality and longevity, enhancing fertility and
libido and alleviating menopausal symptoms in women (Smith, 2014);(Hermann and Bernet, 2009,
Brand, 2016). Different colours of maca hypocotyls are also associated with different health benefits.
For instance, red maca is said to promote prostate health support (The Maca Team, 2016).The most
notable consequence of this popularity has been the Maca Boom in China which led to a drastic surge
in prices, illegal mass cultivation of the plant in China and poses a serious threat to supply and product
quality and safety (Hermann and Bernet, 2009, Smith, 2014, Brand, 2016).
From a pharmaceutical and medical perspective, the enthusiasm for maca is understandable. There are
currently no approved therapeutic drugs to improve sperm quality in men (Cuya et al., 2016). Drugs
available to treat erectile dysfunction like tadalafil and sildenafil and drugs used to treat benign prostatic
hyperplasia like finasteride come with side effects, cautions and contraindication (Joint Formulary
Committee, 2016) and may not be suitable or acceptable to everyone.
The options available to treat menopausal symptoms are few and an increased incidence of breast cancer
and cardiovascular disease has been associated with Hormonal Replacement Therapy (HRT) according
to the Women’s Health Initiative trial (Rossouw et al., 2002). This has spurred many women to look
for non-hormonal alternatives such as herbal remedies to make their transition to menopause easier
(Meissneret al., 2006d, Comhaire and Depypere, 2015, Taylor, 2015)
A wide range of studies on maca, both clinical trials and in vivo and in vitro assays, have been carried
out over the years to examine these health claims. However, the general literature reviews about maca
(Gonzales et al., 2014, Gonzales et al., 2009, Gonzales, 2012) report mostly a compilation of findings
about the in vitro biological properties of maca rather than a critical assessment of all the available
evidence investigating these health claims. There is also no report to our knowledge, detailing how and
5why maca reached such phenomenal recognition and boomed in China in particular. These gaps are
what this study seeks to address.
1.1 AIMS AND OBJECTIVES
The aims and objectives of the present study are:
1) to understand the rise of maca to global prominence
2) to provide an insight into the phytochemistry of maca and discuss factors affecting it
3) to critically evaluate and assess, from a pharmacological perspective, the literature surrounding
the reproductive health claims of maca,
a. as a fertility and libido enhancer and as a treatment for ED and BPH in men
b. as a fertility enhancer and in managing menopausal symptoms in women
2. METHODOLOGY
An initial search of PubMed database was made using ‘Lepidium meyenii’, ‘Lepidium peruvianum’ and
‘maca’ to retrieve articles on the species. Google search was used to find websites of sellers of maca.
An online search of MetaLib using the same terms was also conducted. Specifically, the databases,
EMBASE, AMED (Allied and Complementary Medicine), BioMed Central, Cochrane Library,
PubMed and OVID Journals were searched. Search by hand was also done to retrieve any relevant
references. A key word search was used as it brought more results than a construction of search terms,
for example, any word=(maca) and any word=(menopause). The abstracts of each paper were read to
sort out duplicates, determine their relevance to the topic and triaged accordingly into different folders
in the reference database. Hand searches of the bibliographies of important articles were also conducted.
Papers with no access via UCL were requested through interlibrary loan. The literature is up to date
unitil May 2017.
Papers in Chinese and Spanish were translated and key data extracted [ Spanish -MH; Chinese - Ka Yui
Kum and Andy Chan (London) ]. A database of all references used was constructed using EndNote
online.
3. RESULTS AND DISCUSSION
Early interest in the maca root was mainly in its nutritional value and economic botany (Leon, 1964,
Johns, 1981). Once maca started gaining in popularity in the 1990s, research focused mainly on the
pharmacological actions behind the reproductive health enhancing properties of maca (Wang et al.,
2007). Chemical profiling of the plant progressed to identify the active metabolites and key marker
compounds of the plant. (See Supplementary Appendix 1)
3.1. GENERAL AND ECONOMIC BOTANY
3.1.1. Botanical description
Maca has a rosette of frilly leaves and grows in the harsh climate of Central Andes in Peru, where there
are strong winds and the highest temperature is 12oC (Balick and Lee, 2002, Hermann and Heller, 1997).
Maca is the only domesticated Brassicaceae cultivated for food in the Andes. The edible part, most
commonly described in literature as the hypocotyl or root, is made up of the main tap root and the base
of the hypocotyls (Leon, 1964). Maca root would be referred to as ‘maca root’, ‘root’ or ‘hypocotyl’,
interchangeably throughout the text.
6The species is a self-pollinated octoploid (2n=8x=64) (Leon, 1964)and propagated via sexually
produced seeds. Up to 13 different colours of hypocotyls have been identified ranging from cream to
purple and black, a colouration which depends on the content of carotenoids and anthocyanins in the
outer skin (Clement et al., 2010a, Leon, 1964). The three main colours, also most widely studied, are
red, yellow and black with yellow maca being the preferred variety for its apparently sweeter
taste(Quiros and Cardenas, 1992). Maca is biennial in its natural habitat but has been observed to be
annual in improved conditions of warmer temperatures and under the use of fertiliser (Quiros and
Cardenas, 1992, Hermann and Bernet, 2009)
3.1.2. Botanical Nomenclature
Maca named as Lepidiummeyenii Walp, was first described by German botanist Gerhard Walpers in
1843. Dr. Chacon argued that she discovered a ‘new’ species in 1990, the domesticated maca, different
to the wild maca first described, on the basis of variations in morphological features and proposed to
name it L. peruvianum Chacon but no consensus was reached (Hermann and Bernet, 2009). More
recently, analysis of the two isotypes revealed differences in taxonomy, physical morphology,
phytochemistry and DNA sequences. Lepidpium peruvianum Chacon was deemed the closest
representation of the historically reported maca (Meissner et al., 2015a). While this discrepancy may
pose a significant quality control issue in the trade of maca, both names are considered binomial
synonymous (The Plant List, 2013) and are still used interchangeably in literature.For the purpose of
this paper, the term ‘maca’ refers to both taxonomic names.
3.1.2.1. Maca ecotypes or cultivars?
Based on the literature, a widespread confusion exists about whether the differently coloured forms of
maca hypocotyls should be classified as cultivars, ecotypes or phenotypes, terms that are inherently
different. The seeds of maca are said to result from centuries of cumulative selection by farmers
(National Research Council, 1989). There are some genetic and phytochemical differences between the
different hypocotyl colours (Meissner et al., 2015b, Meissner et al., 2016)but Clement et al.indicates
that all three colours can grow in the same environment(2010a). It was also reported that growth
conditions influence metabolite content more than hypocotyl colour(Zhao et al., 2012, Meissner et al.,
2016)From the gathered information, it is likely that the different hypocotyl colours are a phenotypical
characteristic of the plant and it would be referred to as such in this text.
3.1.3. Local and traditional uses
The common names of Lepidium meyenii include (National Research Council., 1989) maca, Peruvian
ginseng) English), maca, maka, maca-maca, maino, ayak chichira, ayak willku (Quechua and Spanish):.
For over 1,300 to 2000 years maca has been domesticated in San Blas, Junin, (Ondores) Peru and is an
important dietary staple of the indigenous people, used both as food and medicine. It grows at altitudes
of between 4500-5000m (Cobo., 1653 in Gonzales et al., 2009).Maca is used as a tonic to overcome
stress and fatigue, as a fertility enhancer for humans and cattle, as pain reliever for rheumatism, to cure
respiratory disorders, as a laxative and to cure anaemia among others (Leon., 1964, Quiros and
Cardenas., 1992). Andean people consume more than 100g of maca daily (Valerio and Gonzales, 2005).
Maca is traditionally baked in underground pits called pachamanca, boiled and eaten as porridge,
mazamorra, fermented into a sweet drink, macachicha (Ochoa, 2001, Balick and Lee, 2002) and the
cooked roots used in jams, alcoholic cocktails and empanadas (Hermann and Bernet.,2009).
7In 1653, Father Cobo was the first to describe the fertility-enhancing properties of maca (Gonzales GF.,
2011). Inca warriors were fed maca for strength and resilience in battle. Spanish conquests chroniclers
report that maca was taken as tax and fed to livestock to counter their decreasing fertility at high altitudes
(National Research Council., 1989, Quiros and Cardenas., 1992, Balick and Lee., 2002, Gonzales et al.,
2012). Leon., 1964 reported maca consumption among Indian and white women who want to bear
children and as a tonic for postmenopausal women. But one study found that not all Andean farmers
believed that maca enhanced fertility (Locher., 2006 in Hermann and Bernet., 2009). Also, contrary to
purported belief that maca acts as a libido stimulant (Quiros and Cardenas., 1992, Balick and Lee.,
2002), at least one knowledgeable indigenous source indicates that maca was never consumed before
as an aphrodisiac but rather for its invigorating effects. More recent claims of indigenous knowledge
surrounding in particular, improvement of memory and immune system functions, are suggested to be
influenced by the internet hype and maca product promotion arising from the maca boom of the 1990s
(Hermann and Bernet., 2009).
3.1.4. Maca’s transformation into a global commodity
In 1982, maca was slowly falling into decline and was declared in danger of extinction by the
International Board for the Protection of Genetic Resources (National Research Council., 1989). The
1990s sees Maca returning from the verge of extinction pushed by an unprecedented international
interest and is now being touted as Nature’s Viagra, the Peruvian Ginseng. The table below details
maca’s journey (Balick and Lee, 2002, Vecchio, 2007, Hermann and Bernet, 2009, Gonzales, 2012,
Johns, 1981).
Year Milestones
1960 First newspaper article on maca's fertility enhancing effects by Pulgar
1961 Chacon's pioneering thesis reporting acceleration of graffian follicle maturation and improvement in
sperm production in rats
1964 Leon introduces maca to the international audience with his first article on the economic botany of
the plant
1978 Pulgar claims that maca-supplemented heifers have increased fertility as demonstrated through his
own studies. The information is spread nationally through national newspaper articles.
1980 As reported by Vilchez in 1999, only 15 hectares of land are under maca cultivation. A maca beverage
is promoted in a shop on the road to Lima and Huanuco as a tonic to travellers and truck drivers by
the owner Timotea Cordova.
1981 Vilchez starts offering maca roots to several local markets in Central Peru and promotes its health
attributes using printed leaflets to a wider audience. First phytochemical studies of maca are
published.
1982 US students visit Junin and learn about maca
1986 New law ratified by the Peruvian government to promote maca, among other Andean crops. Maca is
introduced to other parts of the Peruvian Andes
1987 Maca gains popularity, especially in the city of Lima. Convenience stores start offering preparations
of maca roots that mask its strong flavour to make it more palatable to urban customers
1980s Efforts to protect maca are stalled as Peru is shaken by the unrest caused by the Shining Path Maoist
Guerrilla.
1991 With the subsiding Guerrilla threat, maca promotion continues. The Food and Agricultural
Organisation of the United Nations recommend maca along with Andean foods to fight malnutrition
1990s Growing academic interest in the species and increasing numbers of studies.
81995 Quimica Suiza, first Peruvian pharmaceutical company invests more than 1 million USD in the
development and branding of maca nutraceutical Maca Andina®. Several companies follow suit and
products are patented
Through
the 1990s
Maca is promoted more aggressively abroad, particularly in Japan. Demand and exports of maca to
Japan, USA and European markets increase. Cultivation of maca intensified with use of mineral
fertilisers and financed by the government, reaches 800 hectares. Maca is exported as pills, capsules,
flour, liquor and extracts.
Maca promotion as the ‘Andean Viagra’ or ‘Peruvian Ginseng’ is also started online.
Between
1998 and
2000
Maca demands in China increases drastically. This pushes prices out of reach of local consumers.
Attempts are made to grow maca abroad.
1999 Pure World Botanicals devises a maca extraction procedure to produce a lipid extract, MacaPure,
with purported claims of increased libido and aiding erectile dysfunction. The extract is US patented
and raises controversy to this day.
2000 Dr. Zheng publishes internationally the first in vivo assay using mice and rats investigating the effects
of MacaPure on fertility through collaboration with researchers in China
2002 The Peruvian government sets up the National Anti-Biopiracy Commission to fight the stealth of
indigenous intellectual property from Peru.
Through
2000s
Maca production and exports continued to expand, reaching exports values of 6,179,011.8 USD in
2010.
Table 1: Timeline of Maca, from ‘anonymity to stardom’
The Peruvian government proved to be too slow and meek to act. The Department of Health in China
approved the cultivation of maca in 2002 and its use as a food resource for health in 2011 (Shu et al.,
2015). In China, a total of 1116.13 hm2 of maca is cultivated in Yunnan, Xinjiang and Tibet yielding
2500t of maca/year and generating an industrial value of 4,359,198 USD and an additional
entrepreneurial value of 14,530,660 USD (Zhou et al., 2015). Chris Kilman also reports a maca boom
whereby the very high demand and prices for the species pushed Chinese red dragon triad to smuggle
maca from the Andes(Smith, 2014). The popularity of maca in China can be related to the belief in
Traditional Chinese Medicine (TCM) system which associates maca, especially black maca (Brand,
2016)with the kidneys; an organ, representing both the storage of energy, Jing and its flow, Chi and is
related to sexual problems in both men and women. The function of the kidneys is lost with ageing, not
recoverable, and damage can only be mitigated. As such, medicines which are believed to enhance its
functions, for example, deer antler base, caterpillar fungus (Ophiocordycepssinensis, (Berk.) G.H.
Sung, J.M. Sung, Hywel-Jones & Spatafora syn.: Cordycepssinensis (Berk.) Sacc.;) and shark fins, are
often very expensive and rare. The introduction of maca, as a less expensive and more available
alternative with its promotion, though without scientific basis, as a libido enhancer and for the kidneys,
helps to explain the maca boom in China (Conversation with Ka Yui, 8th January 2017). The demand
for maca seems to have reached a plateau during the years 2014 to 2015 (Brand, 2016).
3.2. PHYTOCHEMISTRY OF MACA
3.2.1. Nutrition:
Fresh maca has a high water content of more than 80% which makes it a low energy food source with
high nutrient density. It contains 59% hydrolysable carbohydrates, 10 to 16% proteins and 2.2% lipids.
9It is also rich in minerals, essential amino acids and contains a significant amount of Iron and Iodine,
which tend to be deficient in highlands diets (Dini et al., 1994),(National Research Council 1989).
3.2.2. Secondary metabolites:
Chemical profiling of maca has enabled identification of several secondary metabolites. The most
notable ones are: the imidazole, hydantoins and thiohydantoin alkaloids, the alkamides and
glucosinolates and the meyeniins (Cui et al., 2003, Jin et al., 2016, Muhammad et al., 2002, Zhao et al.,
2005, McCollom et al., 2005, Chain et al., 2014, Zheng et al., 2014, Zheng et al., 2003, Li et al., 2001,
Dini et al., 2002, Piacente et al., 2002, Yu et al., 2017b, Zhou et al., 2017; Supplementary Data
SupplementaryAppendix 1.Phytochemicals of maca)
Also reported are phytosterols, polyphenols, tannins, small amounts of saponins and tetrahydromethyl-
β-carboline (Wang et al., 2007, Gonzales and Gonzales-Castaneda, 2009, Leon, 1964, Piacente et al., 
2002).
3.2.2.1. Imidazole alkaloids
Four imidazole alkaloids unique to maca have been identified. They are Lepidiline A, Lepidiline B,
isolated from a concentrated lipid extract of maca (Cui et al., 2003) and lepidiline C and Lepidiline D,
isolated from 95% ethanolic extract of maca (Jin et al., 2016). So far, no information is available about
their possible biological properties.
3.2.2.2 Macahydantoins and macathiohydantoins
Macahydantoins A and B are hydantoins unique to maca. Hydantoins are known to have significant
biological properties. However, none of macahydantoins A or B showed any cytotoxic activity against
five human cancer cells (human promyelocytic leukemia cell HL-60, human hepatocellular carcinoma
cell SMMC-7721, adenocarcinomic human alveolar basal epithelial cell A-549, human breast cell
MCF-7, and human colon adenocarcinoma cell SW480) (Yu et al., 2017b). Macathiohydantoins B-K
are another class of characteristic compounds isolated from maca. They also do not exhibit any
cytotoxic or antimicrobial properties against three bacterial strains (S. aureus, E. coli, and P.
aeruginosa) and three fungal strains (A. fumigatus, C. parapsilosis, and C. albicans) (Yu et al., 2017a).
But structure-wise, these compounds can be of interest.
3.2.2.3. Meyeniins
A new sulfur-containing hexahydroimidazo[1,5-c]thiazole derivatives, (+)-meyeniins A−C were 
isolated as some of the major constituents from the lipidic fraction of maca alongside the macamides,
glucosinolates and macaenes. (+)-meyeniin A showed moderate selective cytotoxicities against the HL-
60, A549 and MCF-7 human cell lines with IC50 values of 14.41, 32.22, and 33.14 μM, respectively, 
supporting use of maca as functional and protective food (Zhou et al., 2017).
3.2.2.4Alkamides
Alkamides, which consists of an amine linked to an unsaturated fatty acid by an amide linkage, are
usually found in the Rutaceae, Asteracecae, Piperaceae and Aristolochiaceae. However, macamides are
alkamides unique to L. meyenii within the Brassicaeae. Macamides are secondary amides formed from
an unsaturated fatty acid moiety linked through an amide linkage to a benzylamine (Greger, 1984,
Esparza et al., 2015). Alkamides can be used as chemotaxonomic or marker compounds to identify
maca and also as a means of standardisation. (McCollom et al., 2005, Zhao et al., 2005, Muhammad et
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al., 2002). However, it should be noted that macamides are not present in whole, undamaged fresh maca
hypocotyls. They occur as a result of traditional Andean practices, which influence the availability of
substrates like free fatty acids and benzylamine resulting from the breakdown of glucosinolates
(Esparza et al., 2015). In nine different commercial preparations of maca, the marker content was found
to vary between 0.15% to 0.84%, indicating a variation in daily intake of these compounds and thus
therapeutic effects associated with them (Granzera et al., 2002). McCollom et al., 2005 also reported
significant variations of marker compounds in samples of maca ranging between 0.0016 to 0.0123% of
dried plant material, from five different vendors. Drying practices during processing may, among other
factors, be responsible for the variations observed. Oven-dried whole maca hypocotyls were found to
have the highest content of macamides while freeze-drying and steaming reduced macamide content
significantly (Pan et al., 2016). This can guide manufacturing protocols for maca-based products
requiring specific macamide content for specific health benefits.
3.2.2.5 Glucosinolates
Glucosinolates have been suggested to be responsible for the fertility-enhancing properties of maca
(Johns, 1981). They are found in the Brassicaceae and confer the pungent aroma and bitter flavour
associated with crucifers. The breakdown products of glucosinolates are biologically active compounds
like indoles, nitriles, thiocyanates and isothiocyanates, which are known to have anti-cancer effects
(Gupta and Prakash, 2014). Of the nine glucosinolates identified in maca, benzyl glucosinolate
(glucotropaeolin) and methoxy-benzyl glucosinolate are the most abundant (Li et al., 2001, Dini et al.,
2002, Piacente et al., 2002) with glucotropaeolin reported making up 80% of glucosinolate content
(Yabar et al., 2011).Fresh maca hypocotyl has also been found to have 10 times more glucosinolate
content than other Brassicaceae species like broccoli and cauliflower inflorescences. The glucosinolate
content decreases significantly after drying and processing of the hypocotyls. For instance, no
glucosinolate was found in tonic and liquor of maca. This is believed to be due to hydrolysis of the
compounds by myrosinase enzyme liberated upon break down of plant tissues (Li et al., 2001, Esparza
et al., 2015).
3.2.2.6Phytosterols
Several phytosterols have been isolated from maca, the main ones being: beta-sitosterol, campesterol,
ergosterol, brassicasterol and stigmasterol (Dini et al., 1994, Wang et al., 2007). Beta-sitosterol showed
higher concentration in the leaves than in the hypocotyls but did not change with respect to other factors
of terrain type and hypocotyls colour (Clement et al., 2010a).
3.2.2.7Fatty acids
20 fatty acids have been isolated as methyl esters (Dini et al., 1994). While, these are commonly referred
to as ‘macaenes’ in literature, Wu et al. suggest a discontinuation of the term ‘macaene’ because no
alkene hydrocarbons have ever been isolated in maca; the only ones being free fatty acids like linolenic
acid, linoleic acid (2013).
3.2.3. Factors influencing the phytochemical composition of maca:
3.2.3.1. Maca hypocotyl’s colour:
The link between maca hypocotyls colour and (secondary) metabolites is still debatable. Yabar et al.
found similar glucosinolate content between yellow, red and black maca hypocotyls (2011). But
Clement et al. observed that lead-coloured maca had higher glucosinolate content than yellow
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hypocotyls, yellow hypocotyls had higher macaenes content and violet maca had higher macamides
content (2010a). Another study found that glucosinolate content among three maca phenotypes varied
as red > black > yellow (Meissner et al., 2015b).
3.2.3.2. Cultivation practices and area of cultivation:
On the other hand, cultivation practices and terrain type will also influence secondary metabolites
content and may have more impact than the maca phenotype itself (Zhao et al., 2012). Maca is known
to be a soil depleting plant to grow and the land is traditionally fallowed for 10 years before planting
again (National Research Council, 1989). However, with the rapidly growing maca market, most
farmers are replanting maca after 4-5 years of fallow only (Hermann and Bernet., 2009). Other studies
have shown that the cultivation area can significantly affect the nutritional and metabolite content of
maca. For example, yellow maca samples grown in China had a higher mineral and protein content than
yellow maca grown in Peru (Zhang et al., 2015, Chen et al., 2017). Additionally, most scientific studies
investigated the properties of Peruvian maca but not Chinese maca (see appendix 2). Considering the
difference in composition between the two types the results obtained with Peruvian maca may not be
correctly extrapolated to Chinese maca.
3.2.3.3. Adulterants and contaminants:
There is also, at least one report from Japan of maca stock heavily contaminated with pesticides
(Hermann and Bernet., 2009) and a health warning issue by the French Food Safety Agency in 2007
concerning the presence of tetrahydromethyl-β-carbolines in maca. However, this was refuted by
Gonzales and Gonzales-Castenadas, 2008, as naturally occurring and non-toxic on consumption. There
are also anecdotal reports of maca adulteration with yam powder (USP Safety Review of Maca, 2012)
and one study also detected a sildenafil analogue, desethylcarbodenafil in a maca-containing herbal
supplement (Huang et al., 2016).
The shift from traditional methods of cultivation and manufacturing of maca to modern ones in new
regions, inevitably affects the composition of the plant. The lack of standard quality control protocols
in place (Li et al., 2001, Shu et al., 2015) renders the quality, efficacy and safety of available maca
products questionable and poses a threat to consumers worldwide. Suggestion about loss of secondary
metabolites from grazing insects as suggested by reviewer number 2?
Fig 2: Peruvian maca and Chinese grown maca studied by Chen et al., 2017( Y – Yellow, P – Purple,
B – Black).
3.3. PHARMACOLOGY
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3.3.1. Maca in male reproductive health: in vivo studies
In some studies, the preparation of aqueous extract of maca for in vivo study purposes was claimed to
reflect a traditional method of preparing maca done by boiling and then filtrating (Gonzales et al.,
2001b, Gonzales et al., 2004, Chung et al., 2005, Bustos-Obregon et al., 2005, Rubio et al., 2006,
Gonzales et al., 2006a, Gonzales et al., 2005).Other extract types have also been investigated and may
help give an indication as to which bio-active compounds are responsible for the observed effects of
maca on male fertility (Zheng et al., 2000, Cicero et al., 2002, Gonzales et al., 2003b, Gonzales et al.,
2007, Gonzales et al., 2008, Yucra et al., 2008, Inoue et al., 2016, Ohta et al., 2016, Zhang et al.,
2016).Maca powder was also tested (Cicero et al., 2001, Clement et al., 2010b, Lavana et al., 2013).
The effects of different maca phenotypes have been investigated(Gonzales et al., 2005, Gonzales et al.,
2006a, Gasco et al., 2007a, Noratto et al., 2013, Inoue et al., 2016). Experimental evidence seems to
suggest that three phenotypes of maca have different physiological effect. For instance, black maca and
to a lesser extent, yellow maca was found to influence sperm production but not red maca. Red maca
and to a lesser extent yellow maca reduced prostate size in rats with testosterone-induced prostatic
hyperplasia but not black maca (Gonzales et al., 2009, Gonzales, 2012).
A number of studies use very high doses of maca extract such as 2.2g/Kg (Rubio et al., 2006),
666mg/Kg BW (Gonzales et al., 2004)and 4g/Kg BW (Zheng et al., 2000)daily. While these may seem
not practical clinically, it has been argued that Andean people consume an average of more than 100g
of maca daily (Valerio and Gonzales, 2005).
3.3.1.1. Spermatogenesis
Several studies have investigated the effects of maca and its extracts on spermatogenesis in rodents and
other animals. Spermatogenesis is the process of formation of sperm cells that occurs in the
seminiferous tubules of the testes (Ray et al., 2015).Stage VIII of the seminiferous tubules epithelium
cycle is the restructuring and release of mature spermatids from the sertoli cells into the seminiferous
tubule lumen. Since, it determines the number of sperm entering the epididymis and thus the sperm
content of the ejaculate, it is viewed as critical for male fertility(O’Donnell et al., 2011; see Appendix
1:in vivo Studies of Maca on Spermatogenesis.
3.3.1.1.1. Influence of aqueous extracts of different maca phenotypes
There is limited evidence to support that aqueous extracts of different maca phenotypes have different
effects on spermatogenesis in rodents. The overarching evidence suggests that aqueous maca extract
increases the frequency of Stage VIII of spermatogenesis often with an accompanying epididymis
weight increase but that the overall sperm count may not necessarily be affected (Gonzales et al., 2001b,
Gonzales et al., 2004, Chung et al., 2005, Gonzales et al., 2006a, Gasco et al., 2007a, Gonzales et al.,
2006b).
Gonzales et al. reported that 666.6mg/day of aqueous extracts from black and yellow maca phenotypes
increased the length of Stage VIII and Epididymal Sperm Count (ESC) in rats at both 7 and 42 days of
treatment but that the red maca aqueous extract did not(2006a). Black maca extract was the only one to
increase Daily Sperm Production (DSP). Likewise, Gasco et al. report that ESC was increased with the
black and yellow maca extracts but not with the red maca extract at a dose of aqueous maca extract
equivalent to 1g of maca/Kg BW. But it is also reported that all three maca phenotypes increased the
sperm count in the vas deferens without affecting DSP after treatment over 84 days(2007a).
Additionally, a dose-related effect on increasing Stage VIII in rats with a yellow maca aqueous extract
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was observed. The smallest effective dose reported was 0.01g/Kg BW and a plateau effect was observed
at 1g/Kg BW of extract (Chung et al., 2005). There is also report of an aqueous extract of black maca
at the dose of 666.6mg/day over 12 days changing the pattern of spermatogenesis but not that of overall
sperm count in rats (Gonzales et al., 2006b).
The lengths of treatment employed and the amounts of extract used vary between studies as does the
methodology. This makes comparison and drawing an accurate conclusion difficult. The limited
available evidence suggests that an aqueous extract of black and yellow maca phenotypes may increase
the pattern of spermatogenesis to some extent but not an aqueous extract of red maca. There is also not
enough evidence to support that black maca or yellow maca aqueous extract increases daily sperm
production.
3.3.1.1.2. Influence of other types of maca extract preparation
Several extracts of maca have also been assessed and the very limited evidence suggests that different
types of maca extracts may have varying effects on spermatogenesis in rodents. A key limitation to
these studies is that the maca treatment is given and assessed over a length of time less than a full cycle
of spermatogenesis in rats, which is 12 days (Aslam et al., 1999 in Gonzales et al., 2006a) or 8.6 days
in mice (Ray et al., 2015). An ethanolic extract of maca, given at 96mg/day showed a decrease in length
of Stage VIII but an increase in lengths of Stage VII and IX-XI with an increase in sperm count
(Gonzales et al., 2003b).
Other extracts investigated, showed that ethyl acetate and chloroform fractions of black maca had a
higher potency in increasing DSP and epididymis sperm count than petroleum ether, n-butanol and
hydroalcoholic fractions when given over 7 days (Yucra et al., 2008). The ethyl acetate fraction and
chloroform fractions are relatively less polar than the n-butanol and hydroalcoholic fractions but
relatively more polar than the petroleum ether fraction (Murov, 2010), this indicates that potential
compounds responsible for the effects observed are likely found in a less polar extract. However,
another study found that the methanolic extractsof yellow and black maca and their respective aqueous
extracts were more effective than their butanolic fractions in improving spermatogenesis in mice at a
dose equivalent to 1g raw material/Kg BW over 3 days(Inoue et al., 2016), indicating the efficacy of a
more polar extract on spermatogenesis. Composition-wise, the methanolic extract and its butanolic
fraction but not its aqueous fraction contained alkaloids. The aqueous fraction also had higher phenolic
content than the butanolic fraction (Inoue et al., 2016). This may mean that polyphenols and not
alkaloids, are responsible for the effects observed on spermatogenesis. While the scarce evidence
available suggests that extract composition will influence the observed effects of maca on
spermatogenesis, it cannot be determined what specific extract fraction is the most conducive to
spermatogenesis. Further research into the extract type, composition and corresponding effect on
spermatogenesis with standardised length of treatment and methodology is required to draw an accurate
conclusion.
3.3.1.1.3. Influence of maca on semen parameters.
The limited evidence available on whether or not maca enhances fertility by improving semen
parameters is inconclusive. In rats treated with yellow maca aqueous extract, no effect on sperm motility
(Chung et al., 2005)was noted but black maca aqueous extract in rats, showed a significant improvement
in sperm motility after 42 days of treatment (Gonzales et al., 2006a). In pre-pubertal breeding bulls fed
a mix of all three dried maca phenotypes at 233mg/Kg BW, an increase in sperm motility was noted
with an increase in ejaculation volume. The effect was noticeable in animals with an initially poorer
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sperm quality and only in those that had been fed for a longer length of time of 10 weeks (Clement et
al., 2010b). However, no increase in ejaculation volume or sperm concentration after an 8 week long
supplementation with milled maca dried hypocotyls in rams at the same dose was noted (Lavana et al.,
2013).
3.3.1.1.4. Protective effects of maca on spermatogenesis
Maca has also been shown to have some protective effects against external noxious factors that can
affect spermatogenesis. For instance, the multi-factorial negative effects of high-altitude exposure on
spermatogenesis in rats were seen to be reversed by administration of 666.6mg/day of aqueous maca
filtrate (Gonzales et al., 2004). Moreover, administration of 66.6mg/day of aqueous maca extract over
21 days was shown to protect the Stages of VII, VIII and IX of spermatogenesis from the inhibiting
effects of a single dose of 80mg/Kg of malathion in mice (Bustos-Obregon et al., 2005). Aqueous
macaextract at a dose of 2.2g/Kg daily in rats was also found to reverse the damaging effect of lead
acetate on Stages VII, VIII and IX-XI of seminiferous epithelium lengths and maintained corpus and
cauda epididymis sperm count, daily sperm count and spermatid count (Rubio et al., 2006).
A study by Cuya et al. of maca on chemically and physically induced sub-fertility in mice also gave
concurring results with 666mg/Kg BW daily of aqueous extract (2016). The inhibiting effect of
Ketoconazole on CYP450 enzyme in the gonadal androgen synthesis pathway seems to have been
reversed with aqueous maca supplementation, preserving sperm count and sperm motility. While in
ELF-MF (extremely low frequency magnetic waves) induced sub-fertility where mitochondrial
function is affected, maca supplementation did not protect sperm parameters but seemed to decrease
occurrence of DNA fragmentation, suggesting anti-oxidant properties(Cuya et al., 2016).
It is plausible to say that the perceived indigenous fertility enhancing properties of maca may stem from
the protective and nutritional properties of maca rather than from a direct effect on sperm production.
3.3.1.2. Prostatic hyperplasia
Benign prostatic hyperplasia entails the enlargement of the stromal and epilthelial cells in the prostate
and an increase in 5-alpha reductase enzyme activity (Diaz et al., 2016). There is some evidence
demonstrating the prostrate-reducing effect of red maca in rodents treated with testosterone enanthate
(TE) to induce prostatic hyperplasia (Gonzales et al., 2005, Noratto et al., 2013, Gasco et al., 2007b,
Gonzales et al., 2007, Gonzales et al., 2008). A reduction in prostate size was also found in the absence
of TE-induced prostatic hyperplasia after 42 days of treatment with red maca (Gonzales et al., 2006a).
This property was more pronounced with the red maca phenotype than in the yellow or black maca
phenotypes (Gonzales et al., 2005, Gonzales et al., 2006a, Noratto et al., 2013). The red maca extract
appeared to be prostrate-specific, unlike finasteride, and did not affect other androgen-dependent organs
like the seminal vesicle(Gasco et al., 2007b, Gonzales et al., 2007, Gonzales et al., 2005, Gonzales et
al., 2012). Doses of 0.1g/Kg BW and 0.5g/Kg BW daily extract was also found to be more effective
than 0.6mg/Kg BW of finasteride in reducing prostate size (Gasco et al., 2007b; seeAppendix 3).
The smallest effective dose of red maca aqueous extract reported is 0.1g/Kg BW. The reduction of
prostate size appeared to be inversely proportional with the dose of extract given (Gasco et al., 2007b).
A similar effect is reported with increasing doses of benzyl-glucosinolate ranging from 0.02 to
0.08mg/ml in red maca extracts (Gonzales et al., 2007). This suggests that benzyl –glucosinolate may
be responsible for the effects on prostrate.
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Boiling time in the preparation of aqueous red maca extract did not significantly affect the effectiveness
of the extract. There was also no difference between the prostate reducing effect of an aqueous and a
hydroalcoholic extract of red maca in rats after 14 days at 1ml of extract (Gonzales et al., 2007).
However, in mice, a 60% hydroalcoholic extract of red maca administered at 140mg/Kg BW did not
produce a reduction in prostate until day 21 but effects on stromal cells were observed from day 7
(Gonzales et al., 2008). This might be due to an inter-species difference or a variation in hydroalcoholic
extract preparation and thus phytochemical composition.
While the limited evidence seems to support that red maca extract can reduce prostate size and may
potentially be used to treat BPH, a key limitation is that the maca extract is administered at the same
time as the TE in the majority of these studies. This means that prostatic hyperplasia would potentially
not have developed before treatment was given, contrary to clinical practice. Indeed, an aqueous extract
of red maca did not reverse the effect of TE on prostate size after day 7 and day 14 of treatment if it
was not administered at the same time TE was first given on day 1 (Gonzales et al., 2012). This suggests
that red maca might have more of a preventative than curative effect in the treatment of BPH but more
research is needed to prove that.
3.3.1.3. Sexual performance
There is some evidence to support that maca can enhance sexual performance in rodents and
rams(Zheng et al., 2000, Cicero et al., 2001, Cicero et al., 2002, Zhang et al., 2016, Lavana et al., 2013).
For instance, the lipid extract of maca standardised to 0.6% macamides and macaenes, increased the
number of complete intromissions at a smallest effective dose of more than 45mg/kg BW. The number
of sperm-positive females also increased significantly when male mice were given a dose of 4g/Kg BW
of the extract (Zheng et al., 2000). Chemical analysis of the extract determined benzylglucosinolate as
a major compound, appearing to concord with the suggestion that glucosinolate may be responsible for
the fertility-enhancing effect of maca (Johns, 1981) and that these are concentrated in that fraction of
maca. However, an investigation to determine which of methanolic, chloroform and hexanic extracts of
maca was more effective in improving sexual performance, delivered debatable results. The hexanic
extract improved only one extra parameter of mount Latency (ML) relative to the methanolic fraction
and both had displayed similar effects (Cicero et al., 2002). Conversely, an ether extract of pulverised
dried maca root was found to be the most effective at improving sexual performance in castrated mice
and more effective than the aqueous or ethanolic extracts. It was suggested that the non-polar ether
fraction may possibly contain alkaloids and aromatic isothiocyanates which may be responsible for the
effects observed (Zhang et al., 2016; seeAppendix 4).
The effects of maca on sexual performance appeared to change with length of treatment and dose
administered. Acutely administered 15mg/kg BW and 75mg/kg BW of pulverised maca root to mice
decreased mount latency (ML), intromission latency (IL) and inter-copulatory interval (ICI). Only
75mg/kg dose decreased post-ejaculatory latency (PEL). Chronically administered both 15mg/kg and
75mg/kg decreased ML, IL, ejaculation latency (EL) and post-ejaculatory latency (PEL) and appeared
to be dose-related while only 75mg/kg decreased ICI (Cicero et al., 2001). On the other hand, an
aqueous solution of maca was found to increase the time to first ejaculation and PEL to a small extent
in rats when administered over seven but not 21 days. The copulatory efficiency and ICI were not
affected. As commented by Dr. Francois Guilliano, the results of the experiment indicate that maca
could potentially be used to treat premature ejaculation in men (Lentz et al., 2007) In contrast, in a study
in rams using dried black maca, Lavana et al. reported an increase in libido measured through increased
number of mounts and ejaculations (2013). The effects of maca were also observed to last 8 weeks after
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maca treatment had stopped (Lavana et al., 2013).Another study found that maca increased sexual
capacity in low performance but not in high performance rams (Avelar et al., 2016)
While the limited evidence suggests that maca extracts can enhance sexual performance, the premise is
still arguable. It is unclear which parameters of sexual performance are increased since all the studies
do not employ the same methodology and do not assess the same parameters or the same number of
parameters (Zheng et al., 2000, Cicero et al., 2001, Cicero et al., 2002, Zhang et al., 2016, Lentz et al.,
2007). It is also uncertain which type of extract, dose or duration of treatment is needed to elicit the
desired effects of enhanced libido.
3.3.1.4. Erectile dysfunction
MacaPure extract also showed an increase in electronically stimulated latent penile erection (LPE) time
in rats fed a dose of 45mg/Kg BW and above with no more increase at higher doses of 180mg/Kg BW
and 1800mg/Kg BW (Zheng et al., 2000). Kimura et al 2016 reports a significant increase in intra-
cavernous pressure to mean arterial pressure ratio in maca treated rats with streptozotocin-induced
diabetes mellitus (SID) relative to untreated rats with SID (2016). These two studies suggest potential
use of maca in treating erectile dysfunction related to hypogonadism and microvascular damage in
diabetes. More research is needed to ascertain the results of these studies (see Appendix 4).
3.3.2. Maca in male reproductive health: Clinical studies
3.3.2.1. Sexual desire
A clinical trial of 56 healthy men using 1.5 to 3.0g daily of gelatinised maca showed a significant
improvement in sexual desire after 8 week but not 4 weeks independently of Hamilton depression and
anxiety scores(Gonzales et al., 2002). Maca also improved subjective sexual desire in men suffering
from Hypoactive Sexual Disorder after 3 months treatment at a lower dose of 960mg/day. Maca
combined with testosterone had a better effect in improving HSD in men with hypogonadism relative
to the use of testosterone only (Poyato et al., 2009). However, with roughly twenty subjects per
treatment group and no regression analysis provided in relation to the Rosenberg self-esteem test score
and PSS-10 test, larger trials taking the psychological element of the condition into consideration, are
needed to confirm the results. In a small pilot study, dyadic sexual desire increased in cyclists after 14
days treatment at 2000mg/day of an aqueous maca extract (Stone et al., 2009).This may suggest that
the aphrodisiac properties are found in the aqueous extract of maca, explaining why the effect was
noticed much earlier than with gelatinised maca but the sample was also very small, which decreases
accuracy of results. Another larger cohort study of 175 participants treated with 3g of spray-dried maca
over a period of 12 weeks showed only a modest increase in sexual desire with red maca relative to
placebo (Gonzales-Arimborgo et al., 2016; See Appendix 4)
3.3.2.2. Erectile dysfunction
Zenico et al. reports a small improvement in erectile dysfunction (ED) and social and physical
performance of STA-P score with maca treatment as measured by International Index of Erectile
Function (IIEF -5) and Satisfaction Profile (SAT-P) (2009). It is postulated by authors, while
considering the limits of the study of mild ED patient within a short period of time, that larger scale
trial run for a longer time and with patients with more serious ED should be done to confirm effect of
maca on ED. The multi-factorial nature of ED involving both a psychological and a clinical component
makes it difficult to identify whether maca improves ED by acting centrally or specifically on the
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reproductive tract(Zenico et al., 2009). Nonetheless, the pilot results look promising and warrant further
investigation in larger scale trials.
3.3.2.3. Semen parameters
Most trials investigating the effects of maca on semen parameters involve relatively small numbers of
subjects and report an improvement in sperm motility after 3 months of maca treatment (Gonzales et
al., 2001a, Tancara et al., 2010, Poveda et al., 2013, Melnikovova et al., 2014). Gonzales et al. reports
an increase in sperm count related to an increase in ejaculation volume (2001a) and Melnikovova et al.
reports an increase in sperm motility and sperm count relative to placebo (2014).Tancara et al. attributes
two pregnancies among the test subjects’ couples to subjects with the highest increase in sperm motility
after 3 hours following the intervention (2010). While, on the other hand, only an increasing trend with
no statistically significant change in semen parameters was observed in a trial of 18 healthy subjects
over 12 weeks (Melnikovova et al., 2015). Similar to the results seen in in vivo studies, the evidence for
improving fertility in men remains inconclusive.
3.3.3.Is there any evidence for androgen-mediated action of maca?
In males, androgens play an essential role in the reproductive and sexual function. For instance,
deficiency of androgen production, specifically testosterone, in the leydig cells in the testes will impair
spermatogenesis, leading to infertility. Testosterone is also important in the development of male sexual
organs (Dohle et al., 2003). Hence, the potential for maca to exhibit androgen-mediated
pharmacological action, which could support its claim as a fertility and libido enhancer in men, is
discussed.
Despite evidence of activity on libido and fertility parameters in men, maca supplementation did not
change serum hormone levels of prolactin, 17-hydroxyprogesterone, testosterone, 17-β estradiol, 
Luteinising Hormone (LH) and Follicle Stimulating Hormone (FSH), suggesting a non-androgen
mediated mechanism of action(Gonzales et al., 2001a, Gonzales et al., 2002, Gonzales et al., 2003a,
Tancara et al., 2010, Melnikovova et al., 2015, Melnikovova et al., 2014).This reflects what was found
in the vast majority of experimental studies on rodents. Apart from a size-reducing effect on prostate
by red maca only, there was no weight change in androgen-dependent organs like seminal vesicles and
testes and no change in serum testosterone levels, with any phenotypes at any doses of aqueous extract
or dry powder of maca tested(Gonzales et al., 2001b, Gonzales et al., 2005, Rubio et al., 2006, Gonzales
et al., 2006a, Gasco et al., 2007b, Gonzales et al., 2007). Furthermore, methanol, ethanol, hexane and
chloroform extracts of maca were unable to regulate glucocorticoid response element activation in
vitro(Bogani et al., 2006). Red maca extract did not affect the viability of human prostate cancer cell
line LNCaP (Diaz et al., 2016).
However, Ohta et al. reported an increase in testosterone level and size of seminal vesicles in pubertal
rats fed with a 60% hydroalcoholic extract of maca (2016). While the developmental stage of the rats
might have influenced the results, a higher level of testosterone production in leydig cells taken from
maca-fed rats and cultivated with 22R-hydroxyprogesterone and pregnenolone in vitro, was also
observed. Feeding hydroalcoholic extract powder of maca to rats was also found to enhance testicular
gene expression of 3β-hydroxysteroid dehydrogenase, the enzyme that catalyses the biosynthesis of 
progesterone from pregnenolone (Ohta et al., 2017). Long-term treatment with hydroalcoholic maca
extract to male rats enhanced steroidogenic ability of Leydig cells and appeared to alleviate the decline
in testosterone production associated with ageing in mature rats (Yoshida et al., 2017). An increase in
seminal vesicle weight and testosterone levels was also noted in mice treated with an ether extract of
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maca (Zhang et al., 2016). Interestingly, a clinical case report was made of maca consumption causing
testosterone assay interference, suggesting that components of maca may have an androgen-like moiety
(Srikugan et al., 2011).
While the presence of an androgen-mediated pharmacological action in vivo remains unclear, other
possible mechanisms of action and responsible bio-actives can be inferred. Gasco et al., who showed a
decrease in prostatic size similar to 5-alpha reductase inhibitor, finasteride, without affecting seminal
vesicle weight(2007b), suggests that maca may potentially be acting at the post-dihydrotestosterone
conversion stage in the testes. Along with reducing prostate size, red maca extract was also found to
reduce intra-testicular zinc levels; increased zinc levels are correlated with increased incidence of
benign prostatic hyperplasia (Gonzales et al., 2012). This suggests that bio-actives in maca likely
modulates some aspect of metabolism or cellular transport in reproductive organs as was speculated
before regarding the effect of black maca on the pattern of spermatogenesis and sperm distribution
(Gonzales et al., 2006b).The synergistic effect of maca with phosphodiesterase inhibitor, taladafil, in
improving erectile dysfunction in rats with streptozotocin-induced diabetes mellitus(Kimura et al.,
2016), and a reversal of CYP450 mediated ketoconazole induced sub-fertility in rats (Cuya et al., 2016),
suggest a possibly enzymatic modulation of maca extract. The pharmacological action of metabolites
in maca remains open to debate.
3.3.4. Maca in female reproductive health: in vivo studies
3.3.4.1. Fertility
The effect of maca consumption on improving the female fertility has been studied mainly through in
vivo studies in intact mice and rats.
With maca powder, an increase in progesterone level in mice and rats was observed but no change in
implantation rate in mice (Oshima et al., 2003, Meissner et al., 2006a). There was also a significant
increase in LH and FSH level but no change in pattern of LH surge (Uchiyama et al., 2014) or estrus
cycles (Gasco et al., 2008). Aqueous extract of red, yellow or black maca did not affect the number of
oocytes, uterine weight (Gasco et al., 2008)or implantation site, gestation length or sex ratio of pups
(Ruiz-Luna et al., 2005). However, maca-treated group had a larger litter size by day 4 post-birth (Ruiz-
Luna et al., 2005)and an improvement in pregnancy rate with increased post-birth survival of pups was
noted with methanol and pentane maca extract (Pino-Figueroa and Maher, 2009). Some of the doses
used in these studies, like 30g extract/Kg BW (Uchiyama et al., 2014)are very unrealistic if translated
to humans (see Appendix 7)
3.3.4.2. Menopause
Ovariectomised rats have been used as a model of menopause and sham operated animals as control to
investigate the claims that maca can help stabilise hormones imbalance during menopause and prevent
associated bone loss. Measurement of organs affected by estrogen and progesterone like the uterus and
hormone levels were made.
Overall, the evidence gathered from in vivo studies is too incongruent to support claims regarding
hormone balance but though scarce, look promising for protection against bone loss (see Appendix 7).
3.3.4.2.1. Hormone levels:
Maca powder administration at a dose of 250mg/Kg BW appeared to decrease Estradiol and
Progesterone levels at 4 weeks (Meissner et al., 2006b) but seemed to increase E2 level at a dose of
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500mg/Kg BW ethanol extract (Zhang et al., 2008) at 7 months and at 1.8g/Kg BW of yellow maca
powder at 7 weeks (Wang et al., 2009). An increase in E2 levels at 28 weeks with 0.096g/Kg of a 0.6%
macamides standardised ethanol extract of maca but not with the higher dose of 0.24g/Kg (Zhang et al.,
2014).
Results for uterine weight also appear inconsistent. While an increase in uterine weight is noted with
1g of aqueous extract/Kg BW in mice (Ruiz-Luna et al., 2005)and a reduction in uterine weight loss
observed with 1.8g/Kg BW pulverized maca in rats (Wang et al., 2009, Barraza et al., 2015), no
restoration of uterine weight following ovariectomisation and treatment with maca was observed with
an ethanol extract at either 0.096g/Kg or 0.24g/Kg (Zhang et al., 2014).
Furthermore no increase in uterine weight was found with yellow, red or black maca when given at a
standardised dose of 4.3mg polyphenol (Gonzales et al., 2010). It is possible that the doses used were
too low in the second instance or that the actives affecting uterine weight not present in the standardised
ethanolic maca extract. While the doses investigated in these studies are very high compared to those
employed in humans in clinical trials, the safety of taking maca as an HRT that does not cause
endometrial hyperplasia is not ascertained. As Dr. Muller emphasized, different patients may have
differing levels of sensitivity to maca administration and the dose should be adjusted accordingly
(Walker, 1998).
On the other hand, maca administration seemed to improve blood lipid profile to some extent without
affecting body weight (Meissner et al., 2006a, Meissner et al., 2006b, Zhang et al., 2008, Wang et al.,
2009, Barraza et al., 2015). ACTH and Cortisol levels were also lowered with an associated anti-
depressant effect (Meissner et al., 2006a, Meissner et al., 2006b).
It is not known whether ovariectomised rats can be used as a model for pre-menopausal women. The
studies also do not report at what stage of the oestrus cycle the control rats or mice are at the time of
the readings of hormone levels. Follicle Stimulating Hormone (FSH), Luteinising Hormone (LH),
Estradiol and Progesterone (PGR) levels would naturally fluctuate (Hubscher et al., 2005) hindering
accurate comparison between the ovariectomised rats and sham operated rats and contributing to
discrepancy of results.
3.3.4.2.2. Osteoporosis
Effects of maca on bone metabolism seemed positive. An increase in bone mineral density, absolute
femur weight, increase in Blood gla protein, a bone formation marker, and a reversal of bone loss after
ovariectomy which was due to increase in trabecular area have been reported. The effects were also
found to be more pronounced with red and black maca over yellow maca (Zhang et al., 2006, Wang et
al., 2009, Gonzales et al., 2010). The positive effect of maca on osteoporosis was also demonstrated in
vitro using MC3-T3 E1 osteoblast-like cell. Macamide N-benzylpalmitamide , promoted cell-
proliferation and a dose-response effect in increasing extracelluar matrix mineralisation at a
concentration of 10-8 M. Importantly, ethanolic extract with same content of N-benzylpalmitamide, had
better effect than the compound alone (Liu et al., 2015), suggesting a synergistic effect of the
metabolites in maca in the protection against bone-loss.
3.3.5. Maca in female reproductive health: Clinical studies
3.3.5.1. Menopause
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There exist several accounts from alternative medicine practitioners and doctors describing how maca
use alleviates menopausal symptoms of hot flashes, night sweats, depression and vaginal dryness and
improves sex life in peri-menopausal and post-menopausal women and in women who had undergone
hysterectomy. This is associated with the belief that maca can restore hormonal balance in menopause
during which, there is a sharp decline in estrogen which causes the onset of menopausal
symptoms(Walker, 1998, Hudson, 2008). Physiologically, the secretion of Luteinising Hormone (LH)
and Follicle Stimulating Hormone (FSH) by the pituitary gland increases significantly as the levels of
Estrogen (E2) and Progesterone (PG) fall in menopause (Fox, 2011; see Appendix 9).
In recent years, several clinical trials have been run to investigate these potential claims. Most suggest
that maca may have some positive effects on menopausal symptoms and hormone levels. However, a
significant positive placebo effect is also reported in all studies, a relatively small sample size is assessed
and no blinding results are provided (Meissner et al., 2005, Meissner et al., 2006e, Meissner et al.,
2006c, Meissner et al., 2006d, Brooks et al., 2008, Stojanovska et al., 2011, Stojanovska et al., 2015).
This undermines the drawing of firm conclusions from results. The fact that four of these studies come
from the same research group (Meissner et al., 2005, Meissner et al., 2006c, Meissner et al., 2006d,
Meissner et al., 2006e) increases the chance of bias.
3.3.5.1.1.Hormone balancing effect of maca
From available evidence, the hormone balancing property attributed to maca is inconclusive. The
earliest studies that assessed the effects of maca over a period of 2 months or more, reported a change
in hormone levels but the results were inconsistent.
For instance, treatment with 2g of maca powder over two months in a group of 20 Caucasian post-
menopausal women appeared to lower FSH levels in one trial (Meissner et al., 2005), increase it in
another (Meissner et al., 2006e) or was not changed relative to placebo in a third trial (Meissner et al.,
2006d). Reports about LH levels were similarly inconsistent with an increase reported by Meissner et
al., 2005 but a decrease reported by Meissner et al., 2006d. On the other hand, an increase in serum E2
levels was reported at the same dose and duration of 2g of maca powder daily over two months
(Meissner et al., 2006e, Meissner et al., 2006d) while Meissner et al., 2005 reported such an increase
only after 8 months of treatment at the same dose.
The difference might be due to the high placebo effect noted and the relatively small sample size used.
Alternating treatment in different sequences of placebo and maca in cross-over design trial, did not
completely mitigate the placebo effects but seemed to support that maca was responsible for the
improvement noted (Meissner et al., 2006c, Meissner et al., 2006d).
Nevertheless, more recent studies, which assessed the effects of maca over a period of 6 weeks and 12
weeks at a higher dose of maca powder at 3.5g daily and 3.3g daily, showed no significant change in
hormone levels relative to placebo and baseline (Brooks et al., 2008, Stojanovska et al., 2011,
Stojanovska et al., 2015).
Interestingly, over 4 weeks at a dose of 3g/day, maca was also found to improve sexual experience with
a significant correlation with change in testosterone levels in a group of 42 pre- and post-menopausal
women suffering from SSRI/SNRI–induced sexual dysfunction (Dording et al., 2015).
3.3.5.1.2. Menopausal symptoms
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The impact of maca treatment on menopausal symptoms has been assessed mainly through
administration of questionnaires. Generally, an improvement in some aspect of menopausal symptoms
is reported by all studies. Menopausal discomfort from hot flushes and night sweating was reduced
along with anxiety, irritability and depression according to both Kupperman Menopausal Index (KMI)
and Greene’s Climacteric Scale (GSC) scores after two months treatment of 2g of maca daily (Meissner
et al., 2005, Meissner et al., 2006c, Meissner et al., 2006d). It is also reported that the improvement
relative to placebo is mainly in psychological symptoms of anxiety, depression and somatic symptoms
(Brooks et al., 2008, Stojanovska et al., 2011, Stojanovska et al., 2015). Improvement in the anxiety
level of a Japanese woman undergoing menopause was also reported (Jikyo et al., 2017)However, both
the GCS scores (Stojanovska et al., 2011, Stojanovska et al., 2015) and KMI scores (Meissner et al.,
2006c) reported a reduction in symptoms with both maca and placebo. Other questionnaires used such
as the Quality of Life SF36-v2 Scale and theWomen's Health Questionnaire Scale revealed significantly
increased scores in general and mental health in both treatment groups (Stojanovska et al., 2011,
Stojanovska et al., 2015). This highlights the limitations of such methods in assessing menopausal
symptoms which are subjective.
3.3.5.1.3. Bone Health
A small scale pilot study investigating the effect of maca on bone density in menopausal women showed
an increase in bone density measures with maca treatment over 4 months but not with placebo (Meissner
et al., 2006d). Considering the small number of participants, six per treatment group, the evidence is
weak and a larger scale trial would be needed to confirm the results.
3.3.6. Is there any evidence for estrogen or progesterone–mediated action of maca?
It seems that when used for periods of at least two months, maca affects female hormones levels of
estrogen and FSH (Meissner et al., 2005, Meissner et al., 2006e, Meissner et al., 2006c, Meissner et al.,
2006d). This suggests that maca would be acting on some hormone-mediated pathway. However,
Brooks et al., 2008 reports that even at physiologically high doses of maca (4mg/ml methanolic extract),
no estrogenic or androgenic action was detected in yeast-based hormone dependent reporter assay. In-
silico estrogen receptor type ER-alpha and ER-beta docking assay revealed no activity from the
phytochemicals of maca (Powers and Setzer, 2015). However, another study found that the macamide
N-benzylpalmitamide, virtually docked to estrogen receptor and increased expression of ER-alpha and
ER-beta genes at 10-7 M in MC3T3-E1 osteoblast-like cell (Liu et al., 2015).
3.4. TOXICOLOGY
Fresh maca is believed to be deleterious to health and natives advise consuming dehydrated and boiled
maca root only. Scientific investigations have found maca to be very safe. No adverse events were
reported in any of the clinical trials (see Appendix 2).in vivo studies demonstrated an LD50 value of
more than 15g/Kg body weight in mice and more than 7.5g/Kg BW in rats (Meissner et al., 2005,
Meissner et al., 2006b, Meissner et al., 2006e). There is one report of maca use causing vaginal bleeding
in a young woman of 24 years old (Srikugan et al., 2011) and one report of a manic episode related to
maca consumption in a 27-years-old male without any psychiatric history (Quandt and Puga, 2016).
None of the adverse events reported according to a 2012 USP Safety Review of Maca, were fatal. This
reflects the use of maca as a food for centuries by the Andean people, who consume on average over
100g of maca root per day (Valerio and Gonzales.,2005).However, an important consideration is the
potential adulteration of maca products arriving on the market with previously unknown and untested
22
substances (Huang et al., 2016) which may have deleterious consequences on the health of
consumers.(See 3.2.3.3 Adulterants and Contaminants)
4. CONCLUSION
The hype surrounding the claims of maca is not completely misleading but the overall evidence is too
limited or lacking to draw any firm conclusions.
Some of the main limitations are that there is not enough information to determine an appropriate
effective dose, frequency of dosing or length of treatment needed to achieve the therapeutic effects
desired. Another is that while Andean people are reported to consume over 100g of maca per day, the
doses used in the clinical trials are comparatively very low and may not bring about the traditionally
believed effects if these are true. There is also a lack of data regarding the type of extract most likely
responsible for the observed effects, indicating that use of whole maca could be preferable. Furthermore,
there is not enough information about the composition of the material under investigation reported in
the literature of pharmacological and clinical studies. Additionally, the extraction solvents used for
chemical profiling are not always similar to the ones used in pharmacological studies. An absence of
any pharmacokinetic data is noted, which renders a guess at the compounds responsible for maca’s
health benefits even harder. These limitations prevent drawing a link between secondary metabolites of
maca, the maca phenotype and the observed therapeutic effect.
Still, the value of maca as a plant of medicinal value cannot be entirely dismissed. Fertility-wise, maca’s
effects appear to stem more from a protective effect against noxious factors rather than from a direct
effect on increasing sperm production and semen parameters. Supporting this hypothesis is the fact that
maca was found to reverse the damage to spermatogenesis from high altitude exposure, malathion and
lead acetate administration in rats. Along the same line, red maca extract was also found to reduce
prostate size in rodents in vivo with TE-induced prostatic hyperplasia if it was administered at the same
time. Benzyl glucosinolate, found in maca, was linked to this prostate reducing effect (Gasco et al.,
2007). Hence, the claim that maca can support prostate health is also not completely invalid.
In women, to our knowledge, there has been no clinical trial conducted to demonstrate the effects of
maca on fertility. But in vivo studies showed an increase in pregnancy rate and survival rate of pups in
rodents. Interestingly, maca was also shown to promote bone health in menopausal women and
ovariectomised rats. Maca extract showed chondro-protective effect in human cartilage samples (Miller
et al., 2006). One in vitro assay demonstrated that the macamide N-benzylpalmitamide, promoted
proliferation of osteoblast cell model MC3T3-E1(Liu et al., 2015). Again, this highlights most likely, a
protective effect of maca. Other studies have indicated significant anti-oxidant and neuroprotective
effects of maca (Sandoval et al., 2002, Valentova and Ulrichova, 2003, Valentova et al., 2006, Pino-
Figueroa, 2009, He et al., 2017), which might be co-responsible for the observed effects.
The libido-enhancing effect of maca seem so far to be positive according to results of in vivo studies in
male rodents but the evidence available is still limited by the methodology employed and the number
of test-subjects. Similarly, though positive, the results of clinical trials are limited by how few studies
have been done, the subjectivity of the experience of libido itself and the small sample size. The
potential of maca to improve sexual dysfunction, however, cannot be completely ignored. In men, the
two clinical trials conducted, showed some improvement in patients with erectile dysfunction. Maca
can be a potential candidate for supportive health supplements to aid with sexual dysfunction resulting
from the treatment of testicular cancer. A single study showed an improvement in sexual experience in
pre- and post-menopausal women with antidepressant-induced sexual dysfunction. It is possible that
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the perceived libido-enhancing of maca is due to its energising properties. The energising and anti-
fatigue properties of maca have been investigated with promising results (Li et al., 2017, Gonzales-
Arimborgo et al., 2016, Yang et al., 2015, Miao, 2015, Tang et al., 2017, Choi et al., 2012). Further
investigation in this area is warranted.
In female menopause, a similar situation arises. Most studies reveal an improvement in psychological
symptoms along with some amelioration of hot flushes according to KMI and GCS scores, following
treatment with maca but they also report a significant positive placebo effect. There was also not enough
evidence to support the hormone balancing of maca in menopause. In both men and women, maca did
not appear to have any hormone-mediated mechanism of action considering the absent and inconsistent
reports of changes in hormone levels in clinical trials and the absence of hormone-mediated activity in
vitro.
From the available evidence, it is more likely that the observed effects of maca are mostly invigorating
in nature and arises from the nutritional properties of the plant which seem to confer some increased
resilience against the stresses of highland living. Chemical profiling has also revealed that maca flaunts
a wide nutritional portfolio including most of the essential amino acids and compounds like
glucosinolates that have previously established anti-oxidant properties. Indeed, in 1991, the Food and
Agricultural Organization of the United Nations had recommended maca among other Andean plants
to prevent nutritional deficits in the Peruvian population.
In light of these findings, it seems that the re-discovery of maca, has led to the distortion of the original
local health claims by dragging it out of context to fit the demands of an emerging global market for
alternative remedies. The financial incentive tied with meeting this international demand has spurred a
rapid, unregulated and unsustainable production and supply of maca. The extent of this problem is such
that the composition of maca products available on the market cannot be accurately gauged and not
much can be confidently said about their safety or health benefits. Importantly, it is not clear how the
commercial production in maca under very different ecological conditions using very different
production systems impacts on the composition of maca. Anecdotal evidence from markets in China
points to American maca being considered to be better and a systematic abalytical/ metabolomics
comparison of the various proveniences and qualities is one of the key needs in order to ascertain best
practice in the supply of maca products. Despite of a lack of data, there can be no doubt that poor quality
is one of the main limitations of maca’s current uses.
While we did not address the multiple questions of sustainable use and benefit sharing, there clearly is
a need to investigate these questions in great detail and to develop strategies for preventing the problems
caused in the boom in Peru (see Smith, 2014; Brand. 2016). In 2017, 25 years after the Convention on
Biological Diversity was signed, the example of maca highlights the need to ascertain not only that
benefit sharing agreements are agreed upon prior to commercialisation, but also that there are much
better regulations of the supply of the materia prima and its processing into a supplement or herbal
medicine. The benefits to the original keepers of knowledge and producers has been minimal at best
and the huge demand has in fact impacted very negatively on the regions of origin. Now that maca is
on the worldwide scene, the need for regulatory measures such as best practice in manufacturing
protocols and honest marketing practices remain. This is necessary to ensure the safety of these
products, protect consumers and enable an educated decision when choosing between treatment options
or when looking for a lifestyle drug.
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In conclusion, while there is some evidence for relevant pharmacological effects, the current main risks
and problems associated with the use of maca are linked to poor and unsustainable products and poorly
managed value chains.
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in vivo studies of maca on spermatogenesis
Properties
investigated
Source of
Maca
Extract and
formulation
Model Dose range
tested
Control used Duration of study Outcomes Comments Reference
(Author.,
Year)
Spermatogenesis
in rats
L. meyenii
root obtained
from
Carhuamayo
(4000m
altitude)
maca root was
prepared
traditionally
by boiling for
30minmin and
filtered to
produce a
filtrate of
67mg/ml of
root. 67mg/ml
aqueous root
extract
3 months old
Holtzman male
rats
1 ml of
67mg/ml
administered
twice daily for
14 days
Untreated
control used
14 days
administration of
the root extract.
Rats were
sacrificed one day
after last dosing.
increased frequency of the Stages IX-XVI of spermatogenesis
and a decreased frequency of the Stages I- VI of
spermatogenesis was observed by day 14. By day 7, increase
Stage VIII (spermiation) was increased. Transillumination
technique was employed to do so. Frequency measured
relative to control which was assigned a value of 1.Weight of
the testicles and the epidiymis were increased but not that of
seminal vesicles discarding the possibility of an androgenic-
like action of maca extract.
Weight of rats in control and
treated groups differed. It is not
clear whether the increased weight
of the epididymis was due to an
increase in sperm production,
considering that it is the frequency
of Stages IX - XIV, which occurs in
the seminiferous tubules, that
increased or because the release of
sperm at Stage VIII which also
increased.
Gonzales et
al., 2001b
Effect of high
altitude on
spermatogenesis
in rats
L. meyenii
from
Carhuamayo
at4000m
altitude
500g of dried
maca root,
pulverized and
boiled in
1500ml water
and filtered.
Filtrate
administered.
Filtrate used
of boiled maca
ratio 1:3 for
30minmin
used.
333.3mg/ml
filtrate
Holtzman
strain three-
months old
adult male rats
666.6mg/day
for altitude
studies; dose-
response study
employed doses
of 0,6.6,66.6
and 666.6
mg/day
Untreated
control used
Altitude study:
days 7, 14 and 21.
Dose-response
study
administered
over 7 days at the
same time as first
7 days of altitude
study
Statistical analysis done. Dose-response study: weight
seemed to increase more rapidly with higher maca doses of
66.6 and 666.6mg/day but mean weight at day 7 were the
same between doses. Epididymal sperm count was
significantly higher in maca-treated rats with the highest
count observed with 666.6mg/day maca. Stage VIII
(spermiation) of seminiferous epithelium cycle increased
with increased maca concentration but no difference
observed at Stages IX-XI. For altitude studies: maca
supplementation at 666.6mg/day prevented weight loss and
decrease in sperm count observed in non-maca treated
group and these were similar to maca-treated mice at sea-
level.
A rise in testosterone, previously
unseen in prior studies on rats and
men treated maca, was noted in
untreated rats at sea-level which
was chalked down to stress from
intubation with vehicle. No such
rise was noted in maca-treated
group even though they were
exposed to intubation as well. This
points towards the potential of
maca as an adaptogen in dealing
with stress. As the reasons for
decrease in spermatogeneis at high
altitude is multi-factorial - increase
in serotonergic action, spurring
weight loss and decreasing
appetite leading to nutritional
deficiency that could contribute
towards decrease in
spermatogeneis - the exact
mechanism of action of maca is as
yet undetermined. It is potentially
due to be, as the authors point out,
to the high nutritional value of
maca, which also contains most of
the essential amino acids, including
arginine.
Gonzales et
al., 2004
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dose-response
effect of maca
on weight of
testes,
epididymis,
seminal vesicles,
liver, kidney,
spleen and
lungs, stages of
seminiferous
tubules,
epididymal
sperm count and
motility, and
serum
testosterone and
estradiol levels
in rats
L. meyenii
from
Carhuamayo
at4000m
altitude,
yellow
ecotype
500g of dried
maca root,
pulverized and
boiled in
1500ml water
for 120min,
cooled,
filtered and
lyophilized. 1g
dry maca
hypocotyl
yielding 0.46g.
lyophilized
aqueous
extract diluted
further for
different
concentrations
Holtzman
strain three-
months old
adult male rats
0.0, 0.01, 0.1, 1
and 5g/kg daily
of lyophilised
aqueous maca
corresponding
to 0.0, 0.022,
0.22, 2.2 and
11.0g daily of
dry maca
hypocotyl.
group
administered
only vehicle
for 0.0 dose -
untreated
control
7 days duration Statistical analysis done. Stage VII-VIII and sperm count
increased with increasing dose of maca administered.
Highest effect observed with dose of 1g/Kg and plateau-d
with higher doses. But no increase in sperm motility
observed. Decrease in seminal vesicle weight observed and
related with drop in serum testosterone levels with 0.01g/kg
and 0.1g/kg dose of maca but not with other doses of maca.
Effect not observed in previous studies with rats and no
decrease in testosterone levels in both men and rats. No
significant increase in body weight or organ weight observed.
1.0g/Kg seems to be optimum dose
for effect on sperm production.
Not necessary to take higher
doses. It seems that increase
spermiation and initial
spermatozoa migration to
epididymis for storage is triggered
by maca administration. Why does
maca increase spermiation without
seemingly affecting serum
testosterone levels is
undetermined
Chung et al.,
2005
effect of maca
on
spermatogenesis
in mice treated
with a single
dose of
malathion
80mg/Kg
L. meyenii
from
Carhuamayo,
Junin
maca root was
prepared
traditionally
by boiling for
30min and
filtered to
produce a
filtrate of
333mg/ml of
root. aqueous
extract
48 Asnesll male
mice 10-12
weeks old
66.6mg
aqueous maca
extract daily
none; group
treated with
malathion
only and
group
treated with
maca only
7,14 and 21 days
observations
post-treatment
Statistical analysis done. Maca was found to protect Stages
VII, VIII, and IX (spermiation) despite inhibiting effect of
malathion.
Fourth group should have been
trial-ed in the same time frame to
decrease possible confounding
variables of time, mice generation
and malathion batch. Mechanism
of action is still unknown.
Bustos-
Obregon et
al., 2005
Effect of
alcoholic extract
of maca on
spermatogenesis
in rats
L. meyenii
from
Carhuamayo,
Junin
dry ethanolic
extract;
hexane
maceration for
3 days at rtp
to remove fat,
ethanolic
filtrate
evaporated to
give dry
extract. Liquid
5% ethanolic
formulation.
Holtzman
strain three-
months old
adult male rats
-
28mg/ml and
48mg/ml
Untreated
control used
7,14 and 21 days
observations
post-treatment
Statistical analysis done. Treatment with the ethanolic
extract of Maca for 7 days resulted in increase of the lengths
of stages VII and IX-XI and a relative reduction in stages XIII-
XIV and II-III of the seminiferous tubules. At the higher dose
of 96 mg/day, a reduction in stage VIII length was also
observed but increase in sperm count was still noted at only
day 7. With lower dose, Stage VIII was no longer increased
after 7days but sperm count was increased relative to control
at all three time points. No change in serum testosterone.
The authors believe that the
aqueous extract has a factor that
increases the length of stage VIII,
which is not present in the
ethanolic extract. The ethanolic
extract has a factor that favors
spermiation and as a result, the
sperm count is constantly elevated
after treatment at 7 days, 14 days
or 21 days with 48 mg/day. This
extract has another factor that
favours the onset and progression
of spermatogenesis, as stages IX-XI
Gonzales et
al., 2003b
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ethanolic
extract
and thereafter XIII-XIV are
increased.
can maca
reverse the
deleterious
effect on
spermatogenesis
of i.p.
administered
lead-acetate in
rats; Parameters
investigated:
length of
seminiferous
stages, weight of
testes,
epidiymis,
seminal vesicles
and ventral
prostate,
testicular and
epididymal
sperm count,
sperm motility,
daily sperm
production
(DSP), sperm
transit state and
serum
testosterone
level
L. meyenii Maca root was
prepared
traditional
method - 500g
of dry and
pulverised
maca root
boiled fro
120min,
cooled and
filtered.
aqueous
extract
Holtzman
strain three-
months old
adult male rats
- 7 per groups
assessed
Lead-acetate
administered:
0,8,16,24mg/kg;
Maca extract:
2.2g/Kg
Untreated
control used
- no lead
acetate and
no maca
lead acetate
administered i.p
from day 1 to 35.
And maca
administered
from day 18 to
35.
Statistical analysis done. Maca extract administration
reversed the damaging effect of lead acetate administration
on Stages VII, VIII and IX-XI of seminiferous epithelium
lengths and on the decrease in corpus and cauda epididymis
sperm count. (no decrease in sperm count was observed
with lead acetate 24mg/kg). Seminnal vesicle weight was not
changed with or without maca. Spermatid count and DSP
decrease with LA was reversed with maca. No change in
sperm transit rate observed. Serum testosterone decreased
with LA and was correlated with decrease in Stages VII- VIII
and IX-XI. However, maca did not reverse decrease in serum
testosterone levels.
Results concord with previous
studies that demonstrated the
promoting effect of maca aqueous
extract on Stage VIII of the
seminiferous epithelium cycle, the
increase in sperm count and the
apparent nil effect on serum
testosterone in rats. The protective
maca against lead acetate
poisoning was also clear. No
explanation given as to why the
24mg/Kg LA group did not have
any effect on sperm count. 7 rats
per group might be too few.
Rubio et al .,
2006
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effects of short-
term and long-
term treatments
of maca
ecotypes red,
yellow and black
on
spermatogenesis
in rats
L. meyenii -
Red Maca,
Yellow Maca
and Black
Maca from
Carhuamayo,
Junin
maca root was
prepared
traditional
method - 500g
of dry and
pulverised
maca root
boiled fro
120min,
cooled and
filtered.
aqueous
extract
Holtzman
strain four
months old
male rats - 6
per group
assessed
666.6mg of
aqueous extract
daily or an
average of
1.66mg/kg BW
daily
Untreated
control
7 days and 42
days duration
Statistical analysis done. After 7days, no change in body
weight and organ weight of testes, epidiymis, seminal
vesicle, kidney, liver, spleen, lungs and heart. But significant
weight decrease of prostate noted with red maca after 42
days. Stage VIII length increased with all 3 maca ecotypes
after 7days. Black maca also increased length of Stage II-VI.
But after 42 days, red maca showed no difference in Stage
VIII length relative to control while both yellow and Black
maca continued to show a significant increase. Yellow and
Black Maca significantly increased epididymal sperm count
but not Red Maca after both 7 and 42 days of treatment.
Only Black Maca increased DSP. No effect observed in
spermatid transit rate with any ecotype. Only Black Maca
showed a significant increase in sperm motility after 42 days
of treatment. No effect observed in serum testosterone,
estradiol and testosterone:estradiol ratio levels with any
ecotypes for any length of treatment.
Black Maca seems to be the most
effective maca ecotype for
promoting male fertility. Yellow
Maca also shows some similar
effect to a lesser extent than black
maca but more than red maca. Red
Maca is least effective if not at all,
in enhancing male fertility.
However, an interesting
observation is in the decrease in
prostate size noted after treatment
with red maca extract after 42 days
,indicating potential use in the
treatment of benign prostatic
hyperplasia.
Gonzales et
al., 2006a
Chronic effect of
Red, Yelllow and
Black Maca on
Daily Sperm
Production
(DSP),
Epididymal
Sperm Count
(ESC), Sperm
Count in the Vas
Deferens (SCVD)
and quantity of
testis DNA.
L. meyenii -
Red Maca
(RM), Yellow
Maca (YM)
and Black
Maca (BM)
varieties from
Carhuamayo,
Junin
freeze-dried
aqueous
extract
obtained after
traditional
boiling process
of 100g of raw
dried maca in
600ml of
water for
60min. - (1g
RM=0.40g
extract), (1g
YM=0.36g
extract) and
(1g BM =
0.56g extract)
3 months old
Holtzman
strain male rats
-8 animals per
dosage group
investigated
Dose equivalent
to 1g of raw
material/Kg
body weight
daily
Untreated
control -
administered
only vehicle
(water) by
gavage
84 days
treatment
Statistical analysis done. Yellow and Black maca increased
ESC but not Red maca. All three RM, YM and BM increased
SCVD without affecting DSP, testis DNA levels and
reproductive organ weight or body weight. No toxicity was
observed through histology of the spleen and liver.
ESC has been shown before to
depend on antioxidant-oxidant
balance in the reproductive tract
with and increase in antioxidant
activity increasing ESC. The results
may point towards the anti-oxidant
activity of maca as shown in
previous studies. The difference in
activity of Black Maca and Yellow
relative to Red maca in increasing
ESC, points towards a difference in
active secondary metabolites. It is
still to be found out whether the
fertility of sperm after maca
treatment is affected or whether
maca affects apoptosis in the
testicles. The effect of maca on
sperm count appears to
modulatory rather than
proliferative.
Gasco et al.,
2007a
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Effect one black
maca on Daily
Sperm
Production
(DSP),
epididymal
sperm and vas
deferens sperm
count in male
rats at days
1,3,5,7 and 12.
L. meyenii-
Black
hypocotyl
variety, from
Carhuamayo
Junin
aqueous
extract,
traditional
boiling process
of 500g in
1500ml of
water for
60min -
333mg
equivalent to
dry hypocotyl
per 1ml of
filtrate
4 months old
Holtzmann
strain male rats
-60 total - 10
rats per group.
corresponding
to dry maca
hypocotyl
weight of 2g/Kg
BW daily
Untreated
control
administered
only vehicle
(water) by
gavage
Treatment groups
at days 1,3,5,7
and 12 days
Statistical analysis done. Black maca administration appears
to change the pattern of daily sperm production without
affecting the sperm count overall in 12 days of treatment
relative to control. Black Maca showed an increase in
epidymal sperm count at days 1,3 and 7 relative to control
but not at days 5 and 12 and an increase in vas deferens
sperm count at day 3,5 and 7 but not at days 1 and 12.
Seminiferous tubular area shows a similar pattern of
decreasing on days 7 and no difference on day 12 relative to
control. Epididymal tubule lumen area also increased on day
7 relative to control and as epididymal sperm count
increased
The results shows that Black maca
interferes with the spermaotogenic
cycle in rats only at the level of
sperm distribution along the
reproductive tract i.e. It has a
modulatory effect. Moreover,
neither intratesticular testosterone
nor serum testosterone levels were
found to change.
Gonzales et
al., 2006b
Elucidation of
which
hydroalcoholic
extract fraction
has most effect
on male fertility
through
parameters of
Daily Sperm
Production
(DSP),
Epididymal
Sperm Count
(ESC) and Vas
Deferens Sperm
Count
L. meyenii -
Black Maca
from
Carhuamayo,
Junin
Hydroalcoholic
extract
prepared with
60% ethanol -
100g of dried
black maca
hypocotyl
produced 7.6g
of
hydroalcoholic
black maca.
Successive
extraction
with solvents
petroleum
ether
(23.7mg),
chloroform
(176.8mg),
ethyl acetate
(207.7mg), n-
butanol
(2.46g), water
fraction
(remaining
aqueous
solution)
(25.93g)
42 adult male
rats of
Holtzman
strain 3 months
old - 7 per
group
1g of raw
material/kg
body weight of
maca
hydroalcoholic
extract.
untreated
control
7 days Statistical analysis done. No significant change in body
weight and weight of reproductive organs cross all groups.
Rats treated with ethyl acetate fraction had higher DSP levels
after 7 days while in the other groups there was no
significant change. Ethyl acetate and chloroform fractions
treated rats showed a higher sperm number in epididymis
than rats treated with petroleum ether, n-butanol, aqueous
fraction and hydroalcoholic extract. No statistically significant
change of hydroalcoholic extract relative to control. Sperm
count in vas deferens was higher in rats treated with
chloroform fraction than those treated with petroleum ether
or ethyl acetate fractions.
It is postulated that the observed
effect of superior potency in
increasing DSP and epididymis
sperm count of ethyl acetate
fraction might be due to the
presence of polyphenols, which are
primarily concentrated in that
fraction and possess anti-oxidant
activity that has been implicated in
increasing sperm number.
Yucra et al.,
2008
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Effect of maca
supplementation
on bovine sperm
quantity and
quality
L. meyenii
from Oca,
Junin and
provided by
Agronaturales,
Lima , Peru -
mix of yellow,
red and black
colours
hypocotyls in
ration of 2:1:1
traditionally
dried
hypocotyl
milled to a
powder of
0.8mm
particle size
and mixed
with oral feed.
No extract.
But dried
hypocotyl
78 peri-
pubertal
breeding bulls
aged between
55 to 84 weeks
with borderline
sperm quality
or ; 23 control
group, 29 maca
early and 26
maca late
groups
233mg/Kg untreated
control
23weeks
including 3 weeks
adaptation period
(2 X 10 weeks). So
maca treatment
given over 10
weeks at a time;
maca early (10 wk
treatment then
10wk placebo)
and maca late (10
wk placebo then
10 wk treatment),
control (20 wk no
treatment)
Statistical analysis. No significant change in body weight,
testes circumference and rectal temperature was observed
with maca treatment. Sperm motility and % frequency of
sperm with damaged chromatin was significantly improved
to a large extent with early maca supplementation (first 10
weeks), more than in bulls with already adequate sperm
quality. Only bulls in the early maca supplementation group
showed a significant increase of 26% in sperm count (also
related to increased ejaculation volume) in the second
10week window., indicating delayed cary-over effects of
maca supplementation.
This finding suggests that maca
supplementation is beneficial only
when applied sufficiently long and
might be even more efficient when
supplemented longer than for 10
wk.
Clement et
al., 2010
determine the
effect of black
maca and camu
camu alone or in
combination on
spermatogenic
cycle in the
seminiferous
epithelium in
adult male rats
using the
transillumination
technique
black maca (L.
meyenii) from
Junin, Peru;
camu camu
(Myrciaria
dubia) from
Iquitos Loreto,
Peruvian
Amazon
aqueous
extraction
prepared by
24hr
maceration in
distilled water
at 4oC
three months
old Holtzmann
strain rats - 6
rats per group
black maca
50mg/day;
camu camu
50mg/d; black
maca+camu
camu at (25mg
+ 25mg)/day
untreated
control (with
vehicle -
distilled
water)
7 days Statistical analysis done. Camu camu had higher total
polyphenol and flavonoid content and higher antioxidant
activity than black maca. Weight of testis, epididymis,
seminal vesicles and prostate did not change significantly
across all groups. DSP and epididymal sperm count was
increased significantly with black maca, camu camu and the
combination of both. Extract of black maca increased lengths
of Stages VII and VIII significantly but not camu camu unless
co-administered with black maca. Black maca alone does not
increase length of Stage XII but co-administration with camu
camu does. Black maca, camu camu and mixture increase
Stages IX-XI w.r.t control. Mixture of black maca and camu
camu was able to increase Stages VII, VIII, IX-XI and XII of
spermatogenesis in rats.
Mitosis occurs at Stages IX-XI;
Meiosis at Stage XII; Spermiation
(release of sperms to the lumen of
the seminiferous epithelium) at
Stage VII-VIII. Therefore, black
maca was acting on mitosis and
spermiation and camu camu was
acting on meiosis. This points
towards different mechanisms of
actions. Changes in spermatogenic
cycle also concords with observed
increase in sperm count in the
epididymis and testis.
Gonzales GF
et al., 2013b
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evaluate the
effect of maca
on chemically
and physically
induced sub-
fertility in male
mice models
L. meyenii -
yellow
ecotype of
maca from
Junin, Peru
methanolic
extract-
fractionated
to butanol
fraction and
aqueous
fraction.
Methanolic
and butanolic
fraction but
not aqueous
fraction were
confirmed to
have alkaloids
from creamy
and orange
precipitate
using Mayer
and
Dragendorff's
reagent
respectively
BALB/c male
mice aged 5-6
weeks old;
chemical sub-
fertility
induced by
administration
of
Ketoconazole
400mg/Kg daily
fro 30 days
before study;
physical sub-
fertility
induced by
exposure to
extremely low
frequency-
magnetic field
(ELF-MF) of
0.55mT and
60Hz (length of
exposure not
specified), field
was monitored
every 2 weeks
666mg/Kg body
weight per day
orally
untreated
control; ELF-
MF sham
exposure
Statistical analysis done. The effect on sperm motility of
chemically induced sub-fertility was apparently reversed with
maca administration to values similar to control group but
not in ELF-MF exposed mice where it improved only by a
little with maca treatment was not significant. The same
trend was observed with the sperm count parameter. Maca
also seemed to have a protective effect against the damaging
effects on sperm DNA fragmentation observed in mice
exposed to ELF-MF, potentially due to antioxidant properties.
Length of treatment of maca not
given. Length of ELF-MF exposure
not mentioned. No report of
testosterone levels if assessed but
increase in testosterone levels
discussed in the discussion section
of paper. But results of study
seems to concord with previous
study of maca in terms of the
sperm motility and sperm count
enhancing properties. Protective
antioxidant effects also observed.
Maca apparently reversed effects
of ketoconazole on cytochrome
P450, restoring the gonadal
androgen synthesis pathway. It
seems maca does not affect
mitochondrial activity as it could
not reverse the effects of ELF-MF
exposure which affects this
parameter.
Cuya et al.,
2016
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effect of
butanolic
fraction of maca
on daily sperm
count,
epididymis
sperm count and
vas deferens
sperm count of
adult mice
L. meyenii -
black maca
and yellow
maca from
Carhuamayo
Junin
no extract. But
milled powder
of black
hypocotyl
90 days old
Swiss strain
mice - 6 per
group
equivalent of 1g
of raw
material/Kg
body weight
daily
untreated
control - 4
mice
3 days Statistical analysis done. Black maca had higher phenolic
content than yellow maca and aqueous fractions of either
had higher TPC than their butanolic fraction. Yellow maca
had more antioxidant capacity than black maca. Methanolic
extract of black maca was more effective than methanolic
extract of yellow maca in increasing sperm count in the
epididymis and vas deferens whereas the methanolic extract
of yellow maca increased DSP more. Butanolic extract values
of DSP and epididymal sperm count were similar to control
indicating no effect.
Study should have confirmed
whether the butanol fraction did
indeed contain MCTA before
making the claim that MCTA in
maca does not affect sperm count.
The fact that the same process of
extraction was used does not
guarantee the same compounds
will be obtained. While macamides
are the compounds characterising
maca, these are primarily
concentrated in the non-polar
fraction. The study and previous
studies have demonstrated the
activity of the polar fraction in
increasing fertility. Since TPC was
higher in aqueous fraction which
also showed significant activity, it
is possible that phenols are
responsible for the activities
observed.
Inoue et al.,
2016
effect of maca
on libido and
semen
characteristics in
hair sheep rams
L. meyenii -
black maca
from
Macandina
thirty 15
months old
proven male
Saint croix
rams
233mg of dried
maca
hypocotyl/Kg
body weight
/day
untreated
control
16 weeks - maca
supplied for first
8 weeks and
normal feed for
next 8 weeks to
assess the
residual effect of
supplementation.
16 weeks covered
2 spermatogenic
cycle
Maca supplementation significantly increased the number of
mounts and ejaculations, decreasing the time between
ejaculations by week 8. no difference was found in reaction
time, time until 1st ejaculation, testes circumference,
ejaculation volume, sperm concentration and ram efficiency
(mounts/ejaculations). These effects persisted 8 weeks later
(residual effect) after no supplementation in the treated
animals.
Authors point out the difference in
physiology between species as a
possible reason for the difference
in results observed. Mechanism of
action of maca is till unknown.
Residual effect of maca suggests a
lingering effect of accumulated or
with longer elimination rate of
specific secondary metabolites or a
combination of these exerting the
effects seen on specific mating
behaviours of increased mounts
and ejaculations after 8 weeks
since treatment was stopped.
Lavana et
al., 2013
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Table ofin vivo studies of maca on Prostatic Hyperplasia
Properties
investigated
Type of
Maca
studied
Extract and
formulation
Model Dose range studied Control used Duration of
study
Outcomes Comments Reference
(Author.,
Year)
effects of
three maca
ecotypes on
testosterone
induced
prostatic
hyperplasia
and prostate
size in rats
L. meyenii -
Red Maca,
Yellow Maca
and Black
Maca from
Carhuamayo,
Junin
aqueous extract.
maca root was
prepared
traditional
method - 500g of
dry and
pulverised maca
root boiled fro
120min, cooled
and filtered
Holtzman rats -
prostate size
study:12 rats per
maca ecotype + 35
rats for control; TE-
induced PH study:
no mention of
number of rats per
group - control, red
maca short term,
red maca long term
Prostate size study:
equivalent of 2g/Kg BW
red maca; TE-induced
PH study: 2g/Kg BW red
maca+ 25mg TE i.m.
Untreated
control
prostate size
study: 7 days;
TE-induced PH:
red maca
treated for 14
days and then
42 days
Statistical analysis done. Red maca significantly
reduced prostate weight but not Yellow or Black
maca. No significant difference observed in body
weight, seminal vesicle weight among rats treated
with different maca ecotypes. No significant change
or difference between ecotype groups in serum
testosterone and estradiol level either. Red maca
significantly reduce prostate weight of rats treated
with TE after 14 days and decreased by more than
50% prostate size of rats treated with TE after 42
days treatment. Red maca reduced the androgen-
dependent prostate epithelium height and luminal
areas in rats treated with TE with apparent
membrane blebbing and nuclear distortion
(suggesting pro-apoptotic effect). Phytochemistry of
reconstituted lyophilized aqueous extract of red
maca with ethanol showed the presence of
alkaloids, steroids, saponins and cardiotonic
glycosides, with absence of flavonoids, tannins,
sesquiterpene lactone and coumarins.
Red maca aqueous extract shows
promising ability to treat benign
prostatic hyperplasia in men.
Possibility of glucosinolate
metabolite form red maca interfering
with androgen action on prostate.
The effects observed might also be
due to anti-proliferative of maca
which can in part be supported from
phytochemical analysis of the extract
which was found to contain a higher
content of glucosinolates than other
ecotypes.
Gonzales
et al.,
2005
Appendix 2: In-vivo Studies of Maca on Prostatic
Hyperplasia
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Effect of
length of
boiling time
on biological
activity of red
maca;
compare
activity of an
aqueous
extract and a
hydroalcoholic
extract of red
maca after
controlling for
glucosinolate
content.
Biological
activity
investigated is
effect on TE-
induced
prostatic
hyperplasia
(PH) in rats.
L. meyenii -
Red Maca
from
Carhuamayo,
Junin
aqueous extract -
one boiled for 2
hours and
another for
3hours;
hydroalcoholic
extract
3 months old adult
Holtzman male
rats; 1) control
(six rats treated
with vehicle); 2) TE
control (15 rats
treated with only
TE); 3) TE + red
maca for 2-h
boiling
(five rats); 4) TE +
red maca for 3-h
boiling (five rats);
5) TE +
hydroalcoholic
extract of red maca
(10 rats);
and 6) positive
control treated
with TE + 0.1 mg
finasteride
(six rats). red maca
extracts used
containted
0.1mg/ml
benzylglucosinolate
; For Dose-
response study -
rats with TE
induced PH,
received red maca
extract with benzyl
glucosinolate
contents of 0.02,
0.04, 0.06 and
0.08mg/ml
benzylglucosinolate
analysed by HPLC
1 mL maca (freeze
dried aqueous extract
or spray dried
hydroalcoholic extract)
given daily to the rats
contained 0.1 mg benzyl
glucosinolates.
Both
negative
(untreated
control and
TE only
treated
control) and
positive
control (TE
and
finasteride
control) used
14 days
administration
of extract. Rats
were sacrificed
one day after
last dosing.
Statistical analysis. Spray-dried hydroalcoholic
extract of red maca had a higher glucosinolate
content than aqueous freeze-dried extract produced
from longer boiling time (3hours). Not much
difference in IR spectra between extracts. Length of
boiling time did not affect the size-reducing' effect
of the two aqueous extracts of red maca on the size
of prostate. Over 14 days administration, finasteride
0.1mg, aqueous freeze-dried extract 0.1mg/ml
benzylglucosinolate and spray-dried hydroalcoholic
extract 0.1mg/ml benzylglucosinolate, all
significantly reduced prostate TE-induced PH in rats.
Finateride also decreased seminal vesicle weight but
not any of the red maca extracts. Dose dependent
reduction in prostate weight with increasing dose of
benzylglucosinolate content (0.02-0.08mg/ml)
observed with no decrease in seminal vesicle
weight.
Both the aqueous and hydoralcoholic
extract of maca containing each
0.1mg/ml benzylglucosinolate,
reduced TE-induced PH to the same
degree. The dose-response effect
observed with varying doses of
benzylglucosinolate also indicated
the importance of the biological
activity of benzylglucosinolate in
decreasing PH. Aqueous extract
results in very polar compounds
being extracted like glucosionlates.
Hydroalcoholic extract can give both
very polar to compounds with lower
polarity. Another factor, aside from
the benzylglucosinolate content
(which varies with heat applied and
in this case no difference was
observed in the final outcome), could
be responsible for observed effect.
Mechanism of action of red maca in
reducing PH is still unclear. It might
be a post-adrogenic receptor
interference since seminal vesical
weight was not changed with red
maca extract, unlike with finasteride
treatment. This would also explain
the absence of changes observed in
serum testosterone and estradiol
levels observed in other studies.
Gonzales
et al.,
2007
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Dose-
response
effect of red
maca TE-
induced
prostatic
hyperplasia
and whether
effect is
comparable to
effect of
finasteride.
L. meyenii -
Red Maca
from
Carhuamayo,
Junin
freeze-dried
aqueous extract
of maca root
suspended in 2ml
water.
3 months old
Holtzman strain
male rats -6
animals per dosage
group investigated
0,0.01,0.005,0.1,0.5g/Kg
BW of freeze-died maca
in 2 ml water
suspension.
untreated
control
(negative),
control
treated with
finasteride
but not red
maca
(positive
control)
21 days. TE
was given on
day 1 and 7.
red maca
extract given
from day 1 to
21.
Statistical analysis done. Red maca was found to
reduce TE-induced prostatic hyperplasia in rats
significantly in dose-response fashion. The red maca
extract doses of 0.1mg/kg BW and 0.5mg/kg BW
were found to be more effective than the dose of
0.6mg/Kg BW of Finasteride administered in
reducing the prostate size in rats treated with TE.
Finasteride but neither of the red maca doses
decreased weight of seminal vesicle. Serum
testosterone level with or without maca treatment
was similar. Red maca extract used was found by
HPLC to have a content of 0.693g/100g.
As effect of red maca was found to
be specific to prostate weight, unlike
Finasteride, a 5-alpha reductase
inhibitor, it was postulated that red
maca extract actives might be acting
at a post-Dihydrotestosterone
conversion level. The presence of
benzylglucosinolate was also found in
the extract used and the anti-
proliferative properties of such
compounds understood to
potentially contribute to the
observed effect.
Gasco et
al., 2007b
Effect of Red
Maca on
prostatic
stroma in
mice with BPH
L. meyenii
from
Carhuamayo,
Junin, Red
Maca
Hydroalcoholic
extract prepared
with 60% ethanol
10 weeks old adult
mice
Red Maca at 140mg/Kg
BW OD; Finasteride
3.6mg/kg BW OD
Positive
control: TE
i.m. +
Finasteride
oral and a
Negative
control:
vehicle oral
+ oil i.m.
TE+Finasteride:
21 days;
TE+RM, 3
groups
assessed at 7,
14 and 21 days
respectively.
Statistical analysis done. No significant difference
between the testis weight and epididymis weight in
mice treated with TE, TE + RM, TE + Finasteride and
vehicle. The weight of the seminal vesicle was not
different in mice treated with TE, TE + RM and TE +
Finasteride. Red maca only produced a significant
reduction in prostate weight induced by TE after 21
days of administration - a possibility that the dose
administered of 140mg/Kg might have been too low.
The reduction in prostatic acinar area (which was
increased by TE) by red maca did not occur until
after 14 and 21 days of administration of extract.
Prostatic epithelial height measurements were not
significantly different between groups. There were
no significant differences between the groups
treated with RM or Finasteride. RM administration
did not modify the serum testosterone and
oestradiol levels in mice treated with TE.
The mice model of TE-induced BPH
seems to be a better model for BPH
in humans because similar to
humans, BPH was observed to
present primarily as an increase or
hyper-proliferation of acinar and
stroma areas with TE. Specificity of
red maca for prostate over androgen-
dependent organs like the seminal
vesicles, testes or epididymis was
demonstrated. The effect on stromal
area was observed as early as 7 days
of treatment with RM, suggesting
that RM might interfere with the
androgen action mainly at the
prostatic stromal cells, exerting its
effects at a stromal and acini level
rather than on epithelial cells.
Authors postulate, following
phytochemical study, that
polyphenols present in maca
aqueous extract and thus most polar
fraction, could be responsible for
reducing prostatic hyperplasia in
mice.
Gonzales
et al.,
2008
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Effect of red
maca on
prostate zinc
levels in rats
with TE-
induced BPH
and to
determine
best marker
for effect of
RM on sex
accessory
glands -
prostate,
seminal
vesicles and
preputial
glands.
L. meyenii -
Red Maca,
from
Carhuamayo,
Junin
aqueous extract
prepared
traditional
method of 100g
dry hypocotyl
boiled with
600ml of water
for 60min,
cooled, filtered
and freeze-dried
thirty-six 3 months
old Holtzman strain
adult male rats; 6
rats per group; BPH
was modelled by
administration of
25mg of TE at day 1
and day 7 in rats
Red Maca: 2g of raw
material /kg BW per
day; Finasteride:
0.1mg/day
untreated
control with
and without
TE
Treatment
from day 1 to
14 and
treatment
from day 7 to
14 with TE
administered
only on day 1
and day 7.
Statistical analysis done. No difference between
testes and epididymis weights between groups. RM
started at day 7 to day 14 did not reduce seminal
vesicles glands, preputial gland and prostate gland
relative to TE treated-only group but Finasteride at
day 7 did reduce prostate size in TE treated-only
group. RM did not reverse the effect of TE-only
treated group. RM at day 1 reversed effect of TE on
preputial gland weight, reduced prostate gland
weight but no that of seminal vesicles unlike
Finasteride at day 1 which reduced all parameters.
RM at day 1 reduced zinc levels in prostate relative
to TE-treated group but Finasteride only partially
reduced it. There was a correlation between higher
zinc levels and BPH.
The results suggest that RM and
Finasteride have different
mechanisms of action in reducing
BPH. RM may potentially decrease
BPH by regulating Zinc levels in
prostate. Also, effect of RM on BPH
may not be seen until at least 7 days
of treatment have been provided.
Whether it is the glucosinolates or
polyphenols in RM that decrease BPH
is not yet known. Prostate weight
and Zinc levels in prostate were
deemed as suitable markers when
using the proposed model to test the
effect of RM on BPH under same
conditions.
Gonzales
et al.,
2012
Whether
consumption
of maca
prevented
BPH in TE-
induced mice
L. meyenii -
Red Maca
and Black
Maca
No mention adult male mice Finasteride
(0.6mg/Kg/day); Red
maca (167mg/Kg/day);
Black Maca
(167mg/Kg/day)
negative
control -
normal mice
administered
vehicle and
mice with
TE-induced
BPH without
treatment
21 days. TE
was given on
day 1 and 7.
red maca,
black maca
extract and
finasteride
given from day
1 to 21.
Treatment with red maca, black maca and
finasteride prevented effects of Testosterone on
prostate. Red maca had a more pronounced effect
in decreasing prostate weight relative to finasteride
and black maca.
Results are concordant with previous
studies that have demonstrated that
red maca has most effect against BPH
induced by TE (Gonzales GF et al.,
2005, Gonzales C et al., 2006,
Gonzales GF et al., 2007b and
Gonzales GF et al., 2008) However,
the mechanism of action red maca is
still undetermined.
Noratto G
et al.,
2013
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Appendix 3:in vivo Studies of Maca on Sexual Performance
Table 3in vivo studies of maca on sexual performance
Properties
investigated
Type of Maca
studied
Extract and Formulation Model Dose range
tested
Control used Duration of study Outcomes Comments Reference
(Author.,
Year)
Sexual
performance,
Erectile
dysfunction
L. meyenii MacaPure- M-01 (contains
more polysaccharide and less
macaene and macamides than
M-02) and MacaPure M-02.
Extracts made from dried
maca roots from Peru through
a process patented by Pure
World Botanicals. Lipid-
extract- 0.6% macaene and
macamides - administered in
10% ethanol as suspension. M-
01 and M-02 was also found to
contain benzyl isothiocyanate
as the major compound and p-
methoxy benzyl isothiocyanate
in smaller amounts.
Mice for sexual
behaviour and
rats for erectile
dysfunction with
castrated male
rats as models of
hypogonadism.
45mg/Kg,
180mg/Kg,
1800mg/Kg of
body weight
Yes. Positive
control used -
testosterone
treated normal
rats. negative
control also used
for ED study
(surgically removed
testes and
untreated with
maca).
22days fed 40mg/Kg
extract study with
mice , also once-only
bolus administration
of 4g/kg extract study
with mice mated after
1 hour of feeding; 20
days fed ED study
with rats
MacaPure M-01 MEC >45mg/Kg
body weight for ED as measured
through LPE; MacaPure M-02
effective at 45mg/Kg for ED. Similar
LPE times of two higher doses of M-
01 and all three doses for M-02
suggest plateau effect - maximum
possible intake by rat models.; Both
effective at 45mg/Kg onwards for
sexual performance.
It is assumed that effect on
Latent Penile Erection (LPE)
can be considered as an
indication for effectiveness
in ED occurring due to
hypogonadism and that
increased rate of
intromissions is indicative
of improved sexual
performance. ;No statistical
test used.; Given the
composition of the
MacaPure extract used, the
effects might be due to
synergy. Results are
indicative of effectiveness
of maca in treating ED and
improving sexual
performance. There were
quite a lot of parameters
and properties investigated
in this one study which
made it difficult to follow.
Zheng et
al., 2000
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Sexual
performance
and locomotor
activity. Sexual
performance
measured as:
first mount
(ML),
intromission
latency (IL),
ejaculation
(EL), post-
ejaculatory
latency (PEL),
Intercopulatory
interval (ICI)
and Copulatory
efficacy (CE)
L. meyenii Pulverised L.meyenii root
standardised at 0.6%
macaenes and macamides
obtained from Santiveri
(Barcelona, Spain) . powder
diluted in saline
normal sexually
trained male
rats.
15mg/Kg,
75mg/Kg or
0.5ml/Kg
saline body
weight
Yes. Untreated
controls. Negative
control - maca
effect on
locomotor activity
tested to remove
association with
increased sexual
performance
15days administration
of maca extract.
Results measured on
first (acute effect) and
last day (chronic
effect)
acutely administered 15mg/kg and
75mg/kg extract decreased ML, IL
and ICI. Only 75mg/kg dose
decreased PEL. Chronically
administered both 15mg/kg and
75mg/kg decreased ML, IL, EL and
PEL. Effect on IL, EL and PEL seems
to be dose-related (increased dose,
decrease parameter). Only
75mg/kg decreased ICI. most part
of tested sexual behaviour occurs
within first 10 minutes of
observation.; In spontaneous
locomotor activity study, no
increased activity was noted until
2nd and 3rd 10 minutes of
observation.
No explanation as to why
acute administration
decreased ICI with both
doses but after 15 days of
chronic administration, only
75mg/kg dose had this
effect. Chronic dosing with
lower dose also contributed
to PEL decrease when it did
not at acute dose -
suggesting a build-up of
actives in the body. In acute
dosing, no mention of EL
parameter results given.
However, results do
confirm like Zheng et al.,
2000 that maca extract
(standardised 0.6%
macaenes and macamides)
improve sexual
performance that is not
related to increase in
spontaneous locomotor
activity as the latter only
increased later indicating
maca takes longer to affect
general activity.
Cicero et
al., 2001
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Extract type on
rat sexual
performance
L. meyenii from
Naturalfa
Quimica Suiza,
collected from
surroundings of
Lake
Chinchaycocha
Hexanic extract; methanolic
extract; chloroformic extract
of maca root. 52mg of hexanic
extracted diluted in saline
administered 0.5ml/Kg; 870mg
of methanolic extract diluted
in saline administered
0.5ml/Kg and 24mg
chloroformic extract diluted in
saline administered 0.5ml/Kg
one hundred 60
days old
Sprague-Dawley
rats
Administration
over 5 days as
per diluted
extract used
Untreated control
used
5 days administration Hexanic extract was found to
improve more parameters of sexual
performance than the other
extracts - methanolic and
chloroform fractions suggesting
that the bioactives of maca thought
to improve sexual performance is
found in this hexanic fraction,
Tentative compounds are
postulated to be glucosinolates.
However benzylglucosinolate has a
Log P value of -0.2 indicating a
greater affinity for the polar
fraction of an extraction solvent.
Also sexually inexperienced
(naive) mice were used and
only 10% of the group
treated with methanolic
extract could complete the
testing procedure. Such a
low rate of participation
would affect results
obtained and furthermore,
hexanic extract increase
only one extra parameter of
ML. Hence, overall
statement that the hexanic
fraction is potentially the
most effective one at
improving sexual function is
questionable. Also
methanol extraction gave
the highest amount of
residue (103.3g). Hexane
extraction gave 6.5g and
Chloroform extraction gave
only 3.0g suggesting that
the majority of bioactives
are in methanol fraction.
Also, hexanic and methanol
fraction were found to have
almost similar effects. It is
possible macaenes and
some more lipophilic
macamides are in the
hexanic fraction while the
less lipophilic macamides
(shorter fatty acid chains)
and the glucosinolates are
in the methanolic fraction.
It is desirable to repeat the
experiment this time with
sexually trained rats
instead.
Cicero et
al., 2002
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effect of maca
on libido and
semen
characteristics
in hair sheep
rams
L. meyenii -black
maca from
Macandina
no extract. But milled powder
of black hypocotyl
thirty 15 months
old proven male
Saint croix rams
233mg of
dried maca
hypocotyl/Kg
body weight
/day
untreated control 16 weeks - maca
supplied for first 8
weeks and normal
feed for next 8 weeks
to assess the residual
effect of
supplementation. 16
weeks covered 2
spermatogenic cycle
Maca supplementation significantly
increased the number of mounts
and ejaculations, decreasing the
time between ejaculations by week
8. No difference was found in
reaction time, time until 1st
ejaculation, testes circumference,
ejaculation volume, sperm
concentration and ram efficiency
(mounts/ejaculations). These
effects persisted 8 weeks later
(residual effect) after no
supplementation in the treated
animals.
Authors point out the
difference in physiology
between species (rams in
this study and bulls in
previous study) as a
possible reason for the
difference in results
observed. Mechanism of
action of maca is till
unknown. Residual effect of
maca suggests a lingering
effect of accumulated or
with longer elimination rate
of specific secondary
metabolites or a
combination of these
exerting the effects seen on
specific mating behaviours
of increased mounts and
ejaculations after 8 weeks
since treatment was
stopped.
Lavana et
al., 2013
effect of
different
fractions of
maca on sexual
performance in
mice, seminal
vesicle weight
and serum
testosterone
levels in
castrated mice
L. meyenii -
pulverised dried
maca root
standardised at
0.6% macamides
and macaenes
offered by MAYA
bio-engineering
Ltd.Co, Huei,
China, collected
from Peru
ether, alcoholic and aqueous
extracts of maca
140 male mice
and 210 female
mice of the
Kunming grade II
strain - 10 mice
per group; rats
to test weight of
seminal vesicles
were
emasculated.
all maca
extracts were
administered
at either
4mg/g body
weight or
0.8mg/g body
weight daily
positive control
treated with
methyltestosterone
and negative
control treated
with 0.9% saline
6 days Statistical analysis done. Maca
significantly increased the number
of complete intromission with all
three extracts, irrespective of dose
and with ether extract being most
effective. Intromission latency was
also decreased but not with
ethanolic extract. Weight of
seminal vesicles of emasculated
mice were increased significantly
when treated with maca extract at
the higher dose or with
methyltestosterone 10mg/g
relative to emasculated control
where seminal vesicles weight had
decreased significantly. There no
significant changes in body weight,
thymus, spleen weight or serum
testosterone levels between maca-
treated group and control.
Ether extract being most
effective in increasing the
number of intromission
suggests that the non-polar
fraction (alkaloids and
aromatic isothiocyanates)
may be responsible for
improving sexual function
in man. This matches what
Cicero et al., found about
hexanic fraction (most non-
polar) increasing copulatory
parameters. Increase in
weight of seminal vesicles
was not found in most
previous studies except in a
recent study by Ohta et al.,
2016. Since no increase in
testosterone levels was
observed in either group,
this may suggest a non-
adrenergic action of maca,
similar to previous studies.
It is also notable that the
increase in seminal vesicle
weight occurred in
Zhang et
al., 2016
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castrated mice with maca
supplementation. It would
have been interesting to
assess the sexual
performance of such mice.
Acute and
Chronic Dosing
of L. Meyenii
(Maca) on
male rat sexual
behaviour; also
effect of
chronic
administration
of maca on
anxiety
L. meyenii aqueous solution of maca male Sprague-
Dawley rats -6-9
animals per
group
25mg/Kg or
100mg/Kg
daily
Untreated control acute testing on day 1
after 25-30min of first
oral administration;
chronic testing on day
7 and day 21 after 4-
7hours of oral
administration
Statistical analysis done. Acute and
daily administration of maca over 7
days increased time to first
ejaculation and post-ejaculatory
latency in rats without affecting
copulatory efficiency and
intercopulatory interval. But the
changes were small. No effect was
observed at day 21. No significant
increase in anxiety or locomotion
observed though the lower dose of
maca group showed decreased
locomotion and the higher dose
maca showed behaviour akin to
less anxiety.
Results do not reflect the
effects observed in previous
studies by Cicero et al.,
2001 where maca appeared
to decrease intromission
and ejaculation latency. The
difference may be due to
the different doses used,
source and preparation of
maca used or experimental
protocol. The study is not
explicit about the source of
maca or its preparation. It
mentions aqueous solution
of maca. However as noted
by Dr. Francois Guilliano,
the results of the
experiment indicates that
maca could potentially be
used to treat premature
ejaculation in men.
Lentz et
al., 2007
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Appendix 4:in vivo Studies of Maca on Erectile Dysfunction
Table 4:in vivo studies of maca on erectile dysfunction
Properties
investigated
Type of
Maca
studied
Extract Model Dose range
studied
Control used Duration of study Outcomes Comments Reference
(Author.,
Year)
Sexual
performance,
Erectile
dysfunction
L.
meyenii
MacaPure- M-01 (contains
more polysaccharide and
less macaene and
macamides than M-02) and
MacaPure M-02. Lipid-
extract- 0.6% macaene and
macamides - administered
in 10% ethanol as
suspension. M-01 and M-02
was also found to contain
benzyl isothiocyanate as the
major compound and p-
methoxy benzyl
isothiocyanate in smaller
amounts.
mice for sexual
behaviour and rats
for erectile
dysfunction with
castacted male rats
as models of
hypogonadism.
45mg/Kg,
180mg/Kg,
1800mg/Kg
of body
weight
yes. Positive
control used -
testeosterone
treated normal
rats. negative
control also
used for ED
study (surgically
removed testes
and untreated
with maca).
22days fed
40mg/Kg extract
study with mice ,
also once-only
bolus
administration of
4g/kg extract
study with mice
mated after 1
hour of feeding;
20 days fed ED
study with rats
MacaPure M-01 MEC >45mg/Kg body
weight for ED as measured through
LPE; MacaPure M-02 effective at
45mg/Kg for ED. Similar LPE times of
two higher doses of M-01 and all
three doses for M-02 suggest plateau
effect - maximum possible intake by
rat models.; Both effective at
45mg/Kg onwards for sexual
performance.
It is assumed that effect on Latent
Penile Erection (LPE) can be
considered as an indication for
effectiveness in ED occurring due to
hypogonadism and that increased rate
of intromissions is indicative of
improved sexual performance. ;No
statistical test used.; Given the
composition of the MacaPure extract
used, the effects might be due to
synergy. Results indicative of
effectiveness of maca in treating ED
and improving sexual performance.
There were quite a lot of parameters
and properties investigated in this one
study which made it difficult to follow.
Zheng et
al., 2000
effect of maca
on glucose
metabolism
and erectile
dysfunction in
streptozotocin
(STZ)-induced
diabetic rats
L.
meyenii
no mention 40 adult male rats
(8 weeks old) - 8
per groups.
Diabetes Type 1
was induced with
single dose
administration of
intra-peritoenal
Streptozotocin at
0.1 citrate buffer
and 60mg/kg body
weight and rats
with blood glucose
levels of 200mg/dL
were considered
diabetic.
Maca at
100mg/Kg
body
weight
daily;
Taladafil at
1mg/Kg
daily
negative control
- untreated;
positive control
of rats with
taladafil
8 weeks Statistical analysis done. Maca
administered group with STZ, even in
combination with Taladafil,
significantly decreased body weight
and blood glucose levels while
increasing significantly the
intracavernous pressure/mean
arterial pressure (ICP/MAP) relative
to STZ diabetic group untreated. STZ
Taladafil treated group also showed
an increase in ICP/MAP.
Maca shows potential for treating
erectile dysfunction in diabetic rats.
The fall of blood glucose levels in also
promising. Authors also report
synergistic effect of maca with
Taladafil which is a phosphodiesterase
inhibitor. Exact mechanism of action
maca still needs to resolved.
Kimura et
al., 2016
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Appendix 6: Clinical Studies of Maca in Men
Table 5: Clinical studies of maca in men
Properties
investigated
Type of
Maca
Maca form
used
Model Dose range
tested
Control
used
Duration of
study
Outcomes Comments Reference
(Author.,
Year)
Semen parameters -
ejaculate volume,
sperm motility,
sperm consistency,
sperm morphology
and sperm
concentration;
blood hormone
levels of: luteinising
hormone, follicle
stimulating
hormone, prolactin
levels, testosterone
and Estradiol E2.
L. meyenii Not an
extract but
gently
cooked at
low heat
maca -
'gelatinised'
to digest the
tougher
fibres and
ease
digestion.
Nine 24-44
years old
normal
healthy man
who did not
have any
medical
intervention
during the
three months
prior to the
study
6 subjects on
1500mg/day
and 3 subjects
on
3000mg/day
None 4 months oral
administration;
fasting blood
test between
08:00 to 09:00
were taken
along with
semen by
masturbation
following 3
days
abstinence at
the beginning
and end of
treatment.
No significant difference noted in
serum hormone levels; Significant
increase noted in ejaculation volume,
total sperm count, motile sperm
count and sperm motility grade a+b.;
No statistical test used.
The seminal vesicles (60%), the
prostrate(30%) and the epididymis (10%)
contribute to the semen volume. All three
are androgen dependent and so is sperm
motility. But no increase in serum
testosterone was found. Mechanism of
action of maca in unknown. It may
potentiate binding of androgens to
receptors or may not have any androgenic
effects at all. The sample size investigated is
also small. No data regarding the maca
tablets used are given. The participants may
not have been honest in following the
guidelines of the study. Other confounding
factors such as a change in diet or exercise
during the study are not accounted for. No
declaration of interest made while the
product from a specific company (Hersil
Laboratories) was used in the study.
Gonzales et
al., 2001a
Effect on sexual
desire and whether
it is influenced by an
improvement in
mental health
scores and hormone
levels because of
maca administration
L. meyenii Tablets
contained
500mg each
of
dehydrated
maca root.
57 healthy
male adults
ages 21-56
years old.
1500mg/day
and
3000mg/day
parallel,
double-
blind,
randomised,
placebo
controlled
study
Treatment
assessment at
points 4, 8 and
12 weeks over
12 weeks
period.
No significant difference in serum
hormone levels in man treated with
maca and placebo.; No significant
difference in self-reported sexual
desire in man treated with maca and
placebo at week 4. But significant
improvement in sexual desire noted
at week 8 and week 12. Maca was
found to improve sexual desire in
men without increasing serum
hormone levels and independently of
Hamilton depression and anxiety
scores when analysed with logistic
regression. No dose-response effect
observed. Statistical analysis used:
Chi-square test, logistic regression
(multi-variate analysis),
Interesting take on maca's effect on sexual
desire in men. It would have been
interesting to see whether and how maca
affected Hamilton anxiety and depression
scores independently. It is ambiguous
whether participants enrolled in the study
are healthy though it is mentioned that
most of them did not smoke or used drugs
in the three months prior to the study.
Hamilton rating scale should also not be
used as a diagnostic test. Mechanism of
action of maca still undetermined. No
declaration of interests but
acknowledgement to Hersil Laboratories -
where was funding taken from?
Gonzales et
al., 2002
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Effect on serum
hormone levels - LH,
FSH, prolactin, 17-
OHP, 17-β-estradiol, 
testosterone
L. meyenii Maca
Gelatinizada
La Molina
tablet 500mg
provided
from hersil
Laboratories
in Lima,
Perum -
500mg each
of
dehydrated
maca root.
56 healthy
male adults
aged 21-56
years old
1500mg - 3
tablets OD;
1500mg - 1
tablet TDS;
3000mg - 2
tablets TDS
parallel,
double-
blind,
randomised,
placebo
controlled
study
Treatment
assessment at
points 2,4, 8
and 12 weeks
over 12 weeks
period.
No significant difference in serum
levels of any of the hormones
assessed were noted. Maca has no
effect on serum hormone levels of LH,
FSH, Prolactin, 17-OHP, 17-β- 
estradiol and testosterone. Time of
administration had no effect either
and neither did the dose
administered. Logarithm applied and
two-way analysis of variance was
done. A multiple regression analysis
was also performed
to determine the independent effect
of treatment, time of
treatment, and serum
hydroxyprogesterone and estradiol
levels on serum testosterone levels
(dependent variable)
Study was thorough and well designed. No
side effect was noted relative to placebo
group.
Gonzales et
al., 2003a
Effect of maca on
hypoactive sexual
desire in men on its
own and relative to
testosterone
L. meyenii no mention 1st group - 31
healthy males
aged 50-62
years old
treated with
maca only;
2nd group -23
males with
Hypogonadism
and no other
sexual
dysfunction
treated with
i.m. depot of
testosterone
and maca ; 3rd
group - 21
males with
Hypogonadism
and no other
sexual
dysfunction,
treated with
i.m depot of
testosterone
only
480mg every
12 hrs daily
None 3 months Maca improved subjective sexual
desire in men suffering from HSD
after 3 months treatment. Maca had a
better effect in improving HSD in men
with hypogonadism relative to use of
testosterone only.
Maca shows potential for improving sexual
desire. No comment made on Rosenberg
test results for self-esteem or PSS-10 test
for perceived stress.
Poyato et
al., 2009
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Effect of maca on
endurance
performance and
sexual desire in
trained cyclists.
Parameters: 40km
cycling time trial
performance and
self-reporting
questionnaire of
Sexual Desire
Inventory (SDI)
L. meyenii
Walp from
Cerro de
Pasco
400mg
capsules
taken orally -
aqueous
extract
obtained
from
maceration
with water;
maca root:
extract
powder ratio
of 5:1
8 male cyclists
aged between
23-37 years
old and were
healthy
2000mg/day placebo -
untreated
control
14 days Statistical analysis done; Maca
supplementation was found to
significantly increase time trial of
40km in cyclist when compared to
pre-supplementation time with no
significant change in Heart Rate or
Rating of Perceived Exertion. Maca
was also found to improve rating of
dyadic sexual desire but not that of
solitary sexual desire. No changes
were observed with placebo
supplementation
Maca apparently increased endurance
performance but it was not related to
increased effort since there was no change
in HR and RPE. However, it should be noted
that the difference between placebo
supplementation and maca
supplementation on time trial improvement
was not significant. Maca was also showed
as in previous studies to improve sexual
desire in men. However, in this study it was
observed at 2 weeks whereas in others it
was shown at 8 weeks (Gonzales et al.,
2002). The number of 8 cyclists might be
too few to confirm finding and larger trials
are needed. mechanism of action of maca
on the investigated parameters are still
unresolved.
Stone et al.,
2009
Subjective effect of
maca on well-being
and sexual
performance of
patients with mild
erectile dysfunction
L. meyenii,
imported
from Peru
and
provided by
Ibersan, Srl,
Forli, Italy.
pulverized
and
dehydrated
maca root -
no extract
used; oral
tablet
50
caucasian31-
41 years old
men with mild
erectile
dysfunction as
measured by
International
Index of
Erectile
Function (IIEF -
5) and
Satisfaction
Profile (SAT-P)
2400mg/day
i.e. 1200mg
twice daily
placebo
controlled
12 weeks trial Statistical analysis done; Maca
treated group experienced a higher
significant increase in IIEF score than
placebo and a higher significant
improvement in psychological
performance SAT-P scores, though
placebo effect was also significant.
But only maca treated group reported
a significant improvement in social
and physical performance of STA-P
score. No significant change in
hormone levels and no report in
adverse events were made during the
study. Maca improving effect on IIEF-
5 scores appeared to be inversely
related to baseline scores.
It is postulated by authors, while
considering the limits of the study of mild
ED patient within a short period of time,
that maca produced a small improvement in
erectile dysfunction relative to placebo and
that larger scale trial run for a longer time
and with patients with more serious ED
should be done to confirm effect of maca
on ED. The multi-factorial nature of ED
involving both a psychological and a clinical
component makes it difficult to identify
whether maca improves ED by acting
centrally or specifically on the reproductive
tract. Nonetheless, the pilot results look
promising and warrant further investigation
on the matter.
Zenico et al.,
2009
The effect of oral
supplementation
with Spermotrend,
Maca extract (L.
meyenii) or L-
Carnothine in semen
parameters of
infertile men
L. meyenii oral 1g pill
Maca extract
from Nature's
Way Product,
Inc - (found
online
standardised
to 3mg
macaenes
and
macamides)
60 infertile but
healthy men
with no
previous
treatment,
non-
alcoholics, non
drug-users
and non-
smokers split
into four
groups for
each
treatment
1g twice daily
or 2g/day
placebo
controlled
Sperm
parameters
evaluated at 0,
30, 60 and 90
days.
Group I (L-carnitine group) showed a
statistically significant increase in
sperm sample concentration. Groups
II (Spermotrend) and III (Maca)
improve the sperm motility (grade
a+b) in the sample more than the
groups I and IV. No difference in the
percentage of normal sperm
(morphology) was found across the
study in any groups.
Maca was shown to improve sperm
motility. This matches the results found by
Gonzales GF et al., 2001 in a pilot clinical
trial on 9 healthy men.
Povedo et
al., 2013
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effect of maca
administration on
semen quality and
serum hormones
levels
L. meyenii Dried milled
maca
hypocotyl
20 healthy
male
volunteers
aged between
20 to 40 years
old
1.75g per day placebo
controlled
sperm
parameters
evaluated at 6
and 12 weeks
of treatment
and blood
hormone
levels
evaluated at
12 weeks of
treatment
Sperm volume and blood hormones
levels did not change significantly
after 3 months of maca treatment.
But there was an apparent increase in
sperm motility and sperm count
relative to placebo.
Quality of sperm was improved
independently of blood hormones levels
with maca treatment.
Melnikovova
et al., 2014
effect of maca
administration on
semen quality and
serum hormones
levels in healthy
adult men
L. meyenii -
yellow
ecotype
from Cerro
de Pasco,
Peru
provided by
Peruvian
company
Andean
Roots SRL.
oral entero
solvent
capsule
containing
350mg
gelatinised
maca powder
each
18 healthy
male
volunteers
aged between
20 to 40 years
old, non
smokers who
did not use
any
substances
that could
change their
hormones
levels 3
months before
treatment;
placebo: 7 and
maca: 11
1.75g per day
or 5 capsules
per day
placebo
controlled
12 weeks trial -
semen
collected
before trial, on
week 6 and
week 12;
blood was
collected
before and
after trial
Statistical analysis done. No
statistically significant changes in
semen parameters were observed,
possibly due to significant within
group variations. However, all semen
parameters showed a rising trend in
the maca group after 12 weeks of
treatment. No statistically significant
changes in serum hormones levels
were observed. Macamides n-
benzylhexadecanamide, n-benzyl-
(9Z.12Z)-octadecadienamide, and n-
benzyl-(9Z.12Z.15Z)-
octadecatrienamide were found to be
the most abundant
It is postulated by authors, while
considering the positive results in previous
trials in men for longer length of time by
Gonzales et al., 2001, that length of maca
treatment positively influences semen
parameters and that maca's effects
warrants further study as a fertility
enhancing agent in men with sub-fertility.
Macamides content, the chemotaxonomic
compounds in lipid maca fraction showed
variations and should ideally be determined
prior to conducting any study.
Melnikovova
et al., 2015
effect of Maca on
spermatogenesis
and spermatic
quality in subjects
diagnosed with
infertility.
L. meyenii pulverized
and
dehydrated
maca root in
capsule
10 males with
alteration in
semen
parameters
classified as
sub-fertility
3000mg/ day None 3 months but
spermatogram
before and
after 3 hours
of treatment
Importantly, no change to sperm
count per ml. Motility and vitality
(only after 3 h) were increased
significantly as was the %-age of
normal sperm cells (from 40 to 45%)
while there was a significant decrease
of immature / twin cells.
It seems that 2 pregnancies (20%) resulted
from the intervention and this is linked to
the main finding, the increased motility 3 h
post intervention. Those subjects with he
highest increase in motility fathered these
children
Tancara et
al., 2010
Compare the effect
of maca
supplementation on
the libido of low v/S
high sexual capacity
hair sheep rams-
investigated are
genital sniffs,
L. meyenii –
black maca
hypocotyls-
maca meal
MacaAndina
Milled
powder
suspended in
250ml water
Animals were
40 sexually
naive Saint
croix rams, 11-
15 months
old, weighing
48.6 ± 8.5 kg
at the
233 mg of dry
maca/kg of
body
weight/day
during four
weeks
10 rams of
each
category:
control diet
with
commercial
concentrate
diet
10 rams in
each control
group: control
diet for 8
weeks or a
maca
supplemented
diet for four
In LP rams, genital sniffs, nudgings
and ejaculations increased (P < 0.05)
during maca supplementation up to
frequencies observed in HP rams,
while mounts increased even at
higher levels. During the residual
phase, all sexual behaviours in LP
rams decreased (P < 0.05; genital
Results suggests that maca
supplementation is not only necessary to
improve sexual capacity, but also to keep it
at high levels. It was concluded that maca
supplementation affects males differently,
according to their sexual capacity. Maca
consumption improves some mating
behaviours in rams. But above all, it
Avelar et al.,
2016
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nudging, mounts
and ejaculations
beginning of
the
experiment;
20 rams high
performers
and 20 rams
low
performers
formulated
for breeding
rams, with
16% protein
(Nutres®
weeks,
followed by
four weeks of
a control diet
(residual
phase)
sniffs, mounts and ejaculations) or
tended to decrease (P > 0.10;
nudging), not to baseline levels, but
to controls. In HP rams, genital sniff
and nudging frequencies increased (P
< 0.05) during maca supplementation,
remaining at high levels during the
residual phase, while mounts and
ejaculations remained unaffected
during the whole experiment. The
number of ejaculations in HP rams
remained similar to their pre-
treatment levels and controls during
the supplementation and residual
phases. These findings suggests that
in HP rams, maca supplementation
might act only as a trigger, favouring a
response in some sexual behaviours
that will remain high, even four weeks
after maca supplementation ceased.
demonstrates that this effect is achieved
particularly by low sexual capacity rams that
will reach high sexual capacity levels, and
that maca supplementation has a short
residual effect.
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in vivo studies for female fertility
Properties investigated Form of maca Model Dose range studied Control
used
Duration of
study
Outcomes Comments Reference
(Authour.,
Year)
steroid hormone levels - 17-β
estradiol in female mice and
testosterone in male mice and
embryo implantation
maca powder
dissolved in
drinking water
(5.0g in 100ml
water) with ad
libitum access
10 three week
old ICR mice(not
sexually mature)
not measureable as
ad libitum access
10 three
week old
ICR mice
on plain
water
30 days No difference in 17-β estradiol serum levels
between treated and untreated groups.
Statistically significant increased in progesterone
levels in female mice in maca treated group
relative to placebo. Statistically significant
difference in testosterone levels in male mice in
maca treated group. No significant difference in
implantation rate between maca treated groups
and untreated groups.
The fact that not sexually mature mice were used
might explain the increase in hormone levels as
these mice reach/grow through puberty during
the study. Ad libitum access to maca powder
does not give control over dosage which makes
drawing a final conclusion elusive. Authors
purport that presence of saponins in maca acting
as an adaptogen might be responsible from
observed effects (Arletti R et al., 1999, Kelly GS.,
2001, Kropotov et al., 2001)
Oshima et
al., 2003
Effects of short and long term
administration of maca powder
and how hormones are related
to observations; Blood
morphology, biochemistry
(lipids, hormones and
minerals), histology of internal
organs were determined,
homogenates of skeletal
muscles and bones of rats
were analysed.
Maca-GO,
pregelatinized
maca powder
suspended in
water
Sprague-Dawley
rats: 45, nine
week old females
weighing 240 g
to 250 g and 45,
twelve weeks
males weighting
340 to 350g at
the beginning of
the experiment.
Trial I (short-
term -28days):
10
animals/group
(5male +5
female), Trial II
(long-term - 90
days): 20
animals/group
(10 male + 10
female)
0.75g/Kg BW and
7.5g/Kg BW by
gavage
Yes, given
vehicle.
28 and 90
days
Maca-Go has low toxicity (LD=7.5g/Kg). There
were different responses of male and female rats
to different levels of Maca-GO administered
during short- and longer-term periods. When
administered at higher dose for extended period
of time (90 days), Maca-GO acted as a toner of
hormonal processes in adult female rats at
increased progesterone and a steady estradiol
level, without affecting levels of blood FSH, LH
and TSH. Substantial decrease in blood cortisol
levels in a short- and longer-term trial and
simultaneous tendency to lower blood ACTH was
observed. After short-term treatment, maca
reduced weight in male rats but did not reduce
weight gain relative to control in female rats
until after long-term treatment. The weight loss
and slowing of weight gain was associated with a
lowering in serum of TSH levels. Triglycerides in
blood plasma were lowered and there was
increasing calcium and phosphorus deposition in
bone and muscle tissues.
Authors advise use of the whole root to achieve
therapeutic effect due to complexity of maca
phytochemistry. Maca showed potential for
further investigation in humans and use in
sportsmen.
Meissner et
al., 2006a
Short and
Long-Term
Physiological
Responses
of Male and
Female Rats
to Two
Dietary
Levels of Pre
Gelatinized
Maca (L.
Peruvianum
Chacon)
reproductive index - fertility
index, gestation index, post-
natal viability index, weaning
viability index, sex ratio index
Yellow maca -
aqueous
extract
lyophilised
11 three months
old virgin female
mice Balb/C
strain
1g extract /Kg body
weight daily
12 three
months old
virgin
female
mice 0.5ml
water by
gavage
15 days prior
to mating,
the whole
gestation
period and
21 days after
birth
(lactation
period)
no significant difference in fertility indexes
measured between groups. No difference in
body weight. No difference in implantation sites,
gestation length, sex ratio or vaginal opening day
of female pups between maca-treated group and
control. Maca-treated group had larger litter size
by day 4 post-birth.
It is suggested that maca may have a protective
effect against resorption during pregnancy,
explaining the higher number of pups. Uterine
weight was also increased in ovariectomised
mice. Postulated mechanisms of action include
increased uterine receptivity, altered immune
function and an effect on the vascular system.
Maca is suggested to have a progestin-like effect.
Ruiz-Luna et
al ., 2005
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varieties of maca on female
reproductive parameters in
adult intact rats
Red, Yellow
and Black
maca -
aqueous
lyophilised
extract
8 three months
old Holtzman
female rats
1g dried hypocotyl
/Kg body weight
daily
8 three
months old
female rats
28 days (7
estrus cycles)
No difference in phases of estrous cycles, body
weight, uterine wet weight and number of
oocytes recovered from oviduct between control
group and maca treated groups. No difference in
serum estradiol level in yellow maca treated
group and control. Black and Red maca-treated
groups not assessed for estradiol level. Total
polyphenols content found in black, yellow and
red maca freeze-dried extracts was 0.56, 0.57
and 0.58 g of pyrogallol/100g, respectively.
Maca did not show any estrogen-like activity. Gasco et al.,
2008
effect of methanol and
pentane extract of maca on
female rat fertility
L. meyenii
methanol and
pentane
extracts
6 female
breeders rats per
group
3mg/Kg BW of
pentane extract,
30mg/Kg BW of
crude extract
6 female
breeders
rats
treated
with
vehicle
only
21 days prior
to mating
Maca-treated animals had 79 pups and 100%
pregnancy rates compared to 56 pups and 67%
pregnancy rate with control. Mortality of pups at
post-natal day 6 was 10.7% for control group and
7.6% and 2.5% for methanol and pentane maca
extract-treated groups respectively. No
difference between groups of weight at birth of
pups and rate of increase in BW through post-
natal day 6.
The doses used are very high (30mg extract/Kg
BW) and not clinically useful.
Pino-
Figueroa
and Maher,
2009
effect of maca on serum LH
during the pro-estrus LH surge
in female rats
L. meyenii -
powder from
Yamano del
Peru SAC,
2 weeks old
Sprague-Dawley
female rats t
beginning of
experiment; 10
in 5% maca
group, 10 in 25%
maca group, 20
in 50% maca
group 20 in
control group
maca powder
mixed to CE2
laboratory chow
feed at 5%, 25%
and 50% and
provided ad libitum
corresponding to
3.0, 15 or 30g/Kg
BW as feed intake
was constant.
20 two
weeks old
female
Sprague-
Dawley rats
in control
group only
with CE2
laboratory
chow feed
7 weeks Serum levels of LH and FSH increased
significantly relative to control. LH serum levels
increases 4.5 times in the pro-oestrus of feeding
with 50% maca powder in female rats. Initiation
time of LH surge, LH surge pattern, elevation of
FSH time and ovulation were not affected with
respect to control group. LH serum levels in the
pulsate LH phase (associated with menopause
and not with an improvement in triggering of
ovulation) did not change either.; There was a
dose-dependent relationship between LH serum
level and amount of maca intake with the
enhancement of LH levels sustained at an intake
of greater than 15g maca/Kg BW.
The dose is very high (30g maca/Kg BW) but
authors explain that it is plausible because
Andean people have traditionally consumed large
quantities of maca and postulate that a high
maca dose might be necessary for fertility in
humans or rats.
Uchiyama et
al., 2014
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in vivo studies of menopause
Properties
investigated
Type of maca
studied
Model Dose range
studied
Control used Control used Duration
of study
Outcomes Comments Reference
(Author.,
Year)
B.1: Hormonal activity
of maca , B.2: blood
morphology, blood
plasma and lipid
levels, B.3:
behavioural and
cognitive function -
anti-depressive, anti-
anxiety, motoric
function and long
term cognitive
function
pre-gelatinised
organic maca
powder (Maca-
GO)
12 OVX and 12
sham-operated
Wistar female
sexually-
experienced
rats weighing
between 330 -
370g
250mg/Kg BW
maca-GO
suspension
twice daily by
gavage
12 OVX and 12
sham-operated
Wistar female
sexually-
experienced rats
weighing
between 330 -
370g given
vehicle (distilled
water) by
gavage
12 OVX and 12
sham-operated
Wistar female
sexually-
experienced rats
weighing
between 330 -
370g given
vehicle (distilled
water) by
gavage
28 days In sham-operated rats, maca-GO decreased Estradiol
(E2) and increased progesterone (PGR) levels. In OVX
rats, maca-GO decreased both E2 and PGR. Maca-Go
lowered ACTH and Cortisol after OVX but did not
normalise Cortisol levels. Maca administration
appeared to restore TSH balance after OVX. After 4
weeks of treatment, there was a slight reduction in
blood cholesterol and triglycerides but no significant
change in blood morphology parameters of
haemoglobin and granulocytes. Total Fe serum levels
did increase as did RBC. Maca-GO showed anti-
depressant like and sedative effects but not
anxiolytic effects, which were associated with
lowered Cortisol and ACTH levels. Maca-Go showed
impairment in spontaneous activity in OVX rats but
not in sham-operated rats. Maca-GO also improved
long-term cognitive function at 48 hours test.
There is no indication at what point of
the estrus cycle were the rats (esp. the
sham-operated ones) when the
measurements were taken. This would
inevitably have influenced the results
of the study. It is suggested that maca
may have some value in protecting
depressive effects in menopausal
women.
Meissner et
al., 2006b (B)
uterine weight in
ovariectomised rats
Yellow maca -
aqueous extract
lyophilised
7 three
months old
virgin female
mice Balb/C
strain were
ovariectomised
and treatment
started3
months post-
surgery
1g extract /Kg
body weight
daily
eight
ovariectomised
mice 0.5ml
water by gavage
eight
ovariectomised
mice 0.5ml
water by gavage
42 day
period
maca-treated significantly increased uterine wet
weight relative to control group
Ruiz-Luna.,
2005
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effect of ethanol
extract of maca on
osteoporosis in
ovariectomised rats
L. meyenii - 95%
ethanol extract
90 day old
female
Sprague-
Dawley rats
ovariectomised
(OVX) - 10 per
group
0.096g
extract/Kg BW
or 0.24g
extract/Kg BW
equivalent to
0.5g and
1.25g of dried
maca root/Kg
BW
respectively
10 sham
operated female
rats and 10
ovariectomised
female rats
given vehicle
(distilled water)
only
10 sham
operated female
rats and 10
ovariectomised
female rats
given vehicle
(distilled water)
only
28 weeks There was no significant difference in body weight
between groups. Uterine weight in OVX and maca
treated group all decreased relative to sham group.
Only femur diameter in maca treated group at
0.24g/Kg BW increased significantly relative to OVX.
The Bone Mineral Density (BMD) of Lumbar
vertebrae LV-6 and calcium content increased
significantly with 0.24g/Kg BW maca treatment
relative to OVX group but there was no change in
mid-shaft femur BMD and ash weight. No significant
difference were observed in femur biomechanical
strength properties of max-load, max-stress, elastic
energy in either sham operated, OVX and OVX-maca
treated groups. No difference in serum calcium and
inorganic phosphorus levels in any groups.
Administration of Maca had no influence on serum
ALP and osteocalcin. Maca administration appeared
to restore architecture in trabecular bone that was
disrupted in OVX rats at both maca doses.
The lack of femur midshaft BMD
decrease is probably due to higher Ca
diet that suppressed cortical bone loss
in OVX rats. The results suggest that
ovariectomy combined with normal Ca
supplementation has less influence on
cortical bone loss. BMD-increasing
effect of Maca is more obvious in
cancellous bone-rich regions than in
cortical bone-rich ones. Since Maca did
not increase bone metabolic markers
in serum while protecting against bone
loss and not increasing uterine weight,
this suggests that maca does not act
directly on the mechanism of bone
metabolism. Maca has a fair amount
of calcium, magnesium and silica that
are easily absorbed and protect
against bone loss. Biological activity of
maca on bone may be due to one or
more phytochemical present.
Zhang et al.,
2006
effect on serum
hormone and blood
lipid levels in
ovariectomised rats
L. meyenii
ethanol extract
ovariectomised
rats as a model
for menopause
0.5g of maca
powder/Kg
BW and 1.25g
of maca
powder/Kg
BW once daily
ovariectomised
rats and sham-
operated rats on
0.1% tween-80
ovariectomised
rats and sham-
operated rats on
0.1% tween-80
7 months Compared with the ovariectomized control rats, the
serum FSH level decreased remarkably (P <0. 01 )
after treated with 1. 25 and 0.5 g·kg-1 of Maca
ethanol extract, the serum E2 level increased (P<0.
01) with 0. 5 g·kg -1, but the serum T level did not
change at the end of 7 th month after
administration. Also, Maca extract definitely
decreased serum cholesterol, while increased serum
triglyceride level in 3rd month but decreased the
level at the end of the administration.
Maca extract definitely improves
endocrine disturbance after
ovariectomy in rats.
Zhang et al.,
2008
effect on body fat,
sexual hormone, bone
metabolism in post-
ovariectomised rats
L. meyenii
(MACA) - yellow
maca pulverised
powder
Sprague-
Dawley rats (5
groups of 11)
low dose
maca
(0.3g/Kg),
middle-dose
maca
(0.6g/Kg),
high dose
(1.8g/Kg)
suspended in
water given
by gavage
sham-operated
and
ovariectomised
rats untreated
sham-operated
and
ovariectomised
rats untreated
7 weeks OVX rats given high dose maca showed an increase
in blood estrogen and Blood gla protein (BGP) level
and had less uterine weight loss and body weight
gain. The triglyceride, LDL-C and ALP level were
similar to sham operated group while these were
increased in untreated OVX group.
Authors suggest dietary
supplementation with maca may help
prevent abnormal lipid levels and help
bone metabolism at post-menopause
by acting through a different
mechanism to estrogen.
Wang et al.,
2009
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effect of different
varieties of maca on
bone structure in
ovariectomised rats
L. meyenii -
Yellow, Red and
Black phenotype -
hydroalcoholic
extract
standaradised to
polyphenol
content
(polyphenol
content of
pulverized dried
hypocotyl varied
as red > yellow >
black);
(polyphenol
content of
hydroalcoholic
extract varied as
yellow > red >
black)
6 three-
months old
female
ovariectomised
(OVX) rats per
group (36
total)
maca dose
equivalent to
4.3mg
polyphenol/Kg
BW
sham operated
female mice and
ovariectomised
female mice
treated with
vehicle; positive
control - OVX
mice treated
with
40microgram/Kg
estradiol
valerate IM daily
sham operated
female mice and
ovariectomised
female mice
treated with
vehicle; positive
control - OVX
mice treated
with
40microgram/Kg
estradiol
valerate IM daily
4 weeks Black and red maca reduced effect of ovariectomy on
absolute weight of femur but not yellow maca. Red
maca also increased dried femur weight relative to
untreated OVX rats’ values. No difference in dried
femur weight in esradiol, black, yellow and sham
groups. Treatment with red, yellow, black and
estradiol reversed the effects of ovariectomy on
femur diameter. Black and red maca showed higher
values in increasing femur width that yellow maca
but there were no significant difference between
groups. Treatment with red or black maca had a
protective effective against bone loss in increasing
trabeculaer bone area and decreasing intra-
trabecular bone space with significant difference
with estradiol treated group. Yellow maca had
similar effects but to a lesser extent. Neither yellow,
black or red maca increased uterine weight in OVX
rats
Maca, especially the red and black
variety, showed protective effects
against bone loss in ovariectomised
rats without increasing uterine weight.
The polyphenols, polyunsaturated
fatty acids and phytosterols found in
maca are thought to be potentially
responsible fro the observed effect. It
is postulated that red and black maca
might be acting as a selective estrogen
receptor modulator (SORM) or a
gonadal steroidogenic acute
regulatory (StAR) protein but further
investigation into the mechanism of
action is needed. The fact that the
study dose was standardised according
to polyphenol indicates that other
metabolites might be responsible for
the effects shown.
Gonzales et
al., 2010
effect of ethanol
extract of maca on
the serum hormone
levels in
ovariectomised rats
and compare these
effects with
diethylstilbestrol
(DES)
L. meyenii -
standardised at
0.6% macaenes
and macamides,
95% ethanol
extract
90-days old
female
Sprague-
Dawley rats -
10 rats per
group
0.096g/Kg BW
and 0.24g/Kg
BW maca
ethanol
extract daily
10 sham
operated female
sprague-dawley
rats untreated ,
10
ovariectomised
female rats
untreated and
10
ovariectomised
female rats
treated with
diethylstilbestrol
at 0.05mg/Kg
daily
10 sham
operated female
sprague-dawley
rats untreated ,
10
ovariectomised
female rats
untreated and
10
ovariectomised
female rats
treated with
diethylstilbestrol
at 0.05mg/Kg
daily
28 weeks maca treated group showed an increase in BW
similar to sham and OVX control groups while DES
group showed a significant decrease. Weight of
uterine was significantly lower in maca and OVX
treated groups relative to sham operated and DES
group showed a significant increase in uterine weight
relative to OVX. No change in Estradiol (E2) and FSH
levels at 12 weeks. Lower dose of maca showed a
significant decrease in testosterone levels relative to
OVX control group. A significant increase in E2 levels
was observed with lower dose maca extract at 28
weeks relative to OVX control. Both maca doses
showed a significant decrease in FSH levels.
Conversely, DES group showed a statistically
significant increase in E2 levels and a statistically
significant decrease in Testosterone and FSH levels at
both week 12 and week 28.
Higher dose of maca did not have an
effect. Maca appear to have some
modulatory effect on hormone
balance in menopausal women but the
mechanism of action is unknown and
the properties of maca in this regard
needs further attention.
Zhang et al.,
2014
to assess effects of
natural supplement
maca and Warmi on
body and uterine
weight and serum
biochemical
parameters in
ovariectomised
female mice
L. meyenii
supplement -
0.5625mg daily
equivalent to
1560mg/60kg
human body
weight
Swiss type
female mice - 4
per group
(twenty total),
ovariectomised
(OVX)
0.5625mg
daily
sham operated
female mice and
ovariectomised
untreated
female mice
sham operated
female mice and
ovariectomised
untreated
female mice
10 weeks OVX group had higher weight than treated group.
Uterine weights in treated group were significantly
higher relative to OVX control group. Triglyceride and
cholesterol levels were lower at the end of the study
in treated group as compared to OVX control group
Maca shows potential in the
prevention of body weight gain, lipid
rise and uterine atrophy after
ovariectomy and warranted further
research. Warmi is a blend of maca
and hesperidin
Barraza et al.,
2015 (focus
on maca only
treatment
group)
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Clinical Studies in women
Study Type Title of study Sample size, condition,
age(years)
Intervention
(regimen)
Control
intervention
(regimen)
Measurement of
menopausal symptoms
Outcome Comment Reference
(Authour.,
Year)
double-blind,
placebo-
controlled
clinical pilot
Use of gelatinized
maca (L.
peruvianum) in early
post-menopausal
women
20 Caucasian healthy
early-menopausal
women for three
months (Trial I), 8 quit,
left with 12 participants
eventually
two placebo
(cellulose and
sorbitol) 500mg
hard gel capsules
twice daily for 1
month followed
by two pre-
gelatinized Maca-
GO 500mg hard
gel capsules
twice daily for
two months
cross-over
study;
placebo
given at two
500mg hard
capsules
twice daily
Luteinising Hormone (LH),
Follicle Stimulating
Hormone (FSH), Estrogen
(E2), Progesterone (PG),
Greene's Menopausal Index
LH level significantly increased with
non-statistically significant decrease in
FSH after 2 months Maca-GO
treatment. Progesterone level
increased during 1st month of placebo
but decreased after two months of
Maca-GO.A positive placebo effect
was observed. Placebo treatment was
reported to decrease nervousness,
fatigue, difficulty falling asleep and
night sweats. Maca-GO treatment for
2 months, correcting for placebo
effect, showed an improvement in
energy, less nervous tension, return of
interest in sex life and reduction in hot
flushes. Night sweating, feeling of
anxiety and depression, excessive
crying and irritability were
inconclusive.
It is suggested that the properties of
maca may be attributed to the peculiar
composition of the plant, especially the
sterols which may have a
multifunctional effect on endocrine
function contributing to the observed
effect. It is postulated that maca may
be acting as a toner of hormonal
processes. The distinctive positive
placebo effect was noted.
Meissner et
al., 2005
(Trial I)
double-blind,
placebo-
controlled
clinical pilot
same as above 8 women for nine
months (Trial II)
two placebo
(cellulose and
sorbitol) 500mg
hard gel capsules
twice daily for 1
month followed
by two pre-
gelatinized Maca-
GO 500mg hard
gel capsules
twice daily for
eight months
cross-over
study;
placebo
given at two
500mg hard
capsules
twice daily
Luteinising Hormone (LH),
Follicle Stimulating
Hormone (FSH), Estrogen
(E2), Progesterone (PG),
Greene's Menopausal Index
Level of FHS significantly decreased
after two months with further
reduction after 8 months of maca-GO
administration. LH was significantly
increased with slight further increased
after 8 months treatment. Levels of
progesterone increased as trial II
progressed but was significant only at
month 8. Estradiol level was also
significantly increased after 8 months
treatment. After correcting for
positive placebo effect, maca-Go
treatment showed a significant
improvement in menopausal
symptoms.
Meissner et
al., 2005
(Trial II)
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double-blind,
cross-over,
randomized,
pilot study
Therapeutic Effects
of Pre-Gelatinized
Maca (L. Peruvianum
Chacon) used as a
Non-Hormonal
Alternative to HRT in
Perimenopausal
Women - Clinical
Pilot Study
20 Caucasian women
(10 per group) aged 41-
50 years old in
perimenopausal stage
(E2 above 40pg/ml and
FSH below 30IU/ml);
women were healthy,
regularly menstruating
and had not used
hormonal treatment
before
Two Maca-Go
(dried pre-
gelatinized and
pulverized maca
hypocotyl)
500mg hard
capsules twice
daily for two
months. Maca
root in
distribution of
16% black,
48%yellow and
9% red/purple.
cross-over
study;
placebo
given at two
500mg hard
capsules
twice daily
Estrogen (E2), Follicle
Stimulating Hormone (FSH),
Luteinising Hormone (LH),
Progesterone (PGS), Cortisol
(CT), Adrenocorticotrophic
Hormone (ACTH), Thyroid
Hormones (TSH, T4, T3),
minerals (Ca, K, Fe) and lipid
profiles (Triglycerides, Total
Cholesterol, LDL, HDL), body
weight, blood pressure,
Kupperman's Menopausal
Index
There was a distinctive placebo effect.
Significantly alleviated symptoms of
menopausal discomfort (hot flushes,
night sweats, interrupted sleep
patterns, nervousness, depression and
heart palpitations) in 74-87% of
women according to Kupperman's
Index. There was a significant increase
in E2, FSH, PGS, ACTH, HDL and Iron
and reduction in blood pressure, body
weight, Triglycerides and cholesterol
levels.
A possible hormone balancing and
toner effect of maca acting on the
hypothalamus and pituitary is
postulated.
Meissner et
al., 2006e
double-blind,
randomised,
placebo-
controlled,
multi-centre
clinical study
Hormone-Balancing
Effect of Pre-
Gelatinized Organic
Maca (L. peruvianum
Chacon): (II)
Physiological and
Symptomatic
Responses of Early-
Postmenopausal
Women to
Standardized doses
of Maca in Double
Blind, Randomized,
Placebo-Controlled,
Multi-Centre Clinical
Study
102 healthy Caucasian
women aged 49- 58
years old and with
follicle stimulating
hormone (FSH) >30
IU/ml and estrogen (E2)
<40 pg/ml levels at
admission.
two 500mg
vegetable hard
gel capsules of
maca-GO powder
twice daily for
three months; 62
women given
(placebo-maca-
maca) and 40
women given
(maca-maca-
placebo)
two 500mg
placebo
capsules
twice daily
for three
months
blood levels of FSH, E2,
progesterone (PRG) and
luteinising hormone (LH),
serum cholesterol (CHOL),
triglycerides (TRG), high-
and low density lipoproteins
(HDL and LDL); Greene's
Menopause Score (GMS)
and Kupperman's
Menopause Index (KMI)
There was no statistically significant
difference between the two sequence
groups (APMM and AMMP) in the
levels of the four hormones profile
recorded on a monthly basis in any of
the four blood sampling points. It
seems at least two months of maca-
GO treatment are needed to bring
down TGL, LDL and increase HDL.
Placebo treatment for one month
caused a decrease in 11 of KMI
symptoms and after following two
months with maca-GO, there were no
change in KMI symptoms relative to
that recorded with placebo but a
significant improvement in hot flushes
and nervousness were reported. GMS
scores with maca-GO treatment
relative to placebo showed a
significant improvement in hot
flushes, excessive sweating,
nervousness, excessive alertness, lack
of energy/feeling of tiredness and to a
lesser degree irritability and
headaches. Effects were more
pronounced after 2 months treatment
with maca-GO.
Failure to comply to treatment
protocol and drop-outs were not
counted in the final statistical analysis
(no Intent-to-treat analysis). It seems
that placebo effect is significant in
bringing desired increase in E2 levels.
KMI and GMS Scores were consistently
improved.
Meissner et
al., 2006c
(Trial I)
65
double-blind,
randomised,
placebo-
controlled,
multi-centre
clinical study
same as above; Trial
II aims to study the
placebo effect when
introduced in
different sequence
alongside maca
treatment
66 healthy Caucasian
women aged 49- 58
years old and with
follicle stimulating
hormone (FSH) >30
IU/ml and estrogen (E2)
<40 pg/ml levels at
admission.
two 500mg
vegetable hard
gel capsules of
maca-GO powder
(pre-gelatinised
organic maca
powder) twice
daily for four
months; six
individual
treatment
sequences were
used (A-P-M-M-
P; A-P-P M-M; A-
M-M-P-P; A-M-
M-P-M; A-P-P-P-
M; A-M-M-M-P).
Eleven women
were assigned to
each treatment
sequence.
two 500mg
placebo
capsules
twice daily
for four
months
blood levels of FSH, E2,
progesterone (PRG) and
luteinising hormone (LH),
serum cholesterol (CHOL),
triglycerides (TRG), high-
and low density lipoproteins
(HDL and LDL); Greene's
Menopause Score (GMS)
and Kupperman's
Menopause Index (KMI)
Maca did not seem to have any
residual effect while it did tend to
lower FSH whilst on treatment. E2
levels increased significantly in
APPMM sequence and almost
significantly in AMMPM sequence.
Two months of maca treatment
showed a more pronounced effect on
decreasing FSH levels and increasing
E2 levels than one month treatment
only. No change in progesterone
levels. Significant improvement in KMI
and GMS scores were more
pronounced after two months
treatment with maca-GO.
Authors state that it is reasonable to
assume that Maca-GO, although it
contains no plant hormones,
stimulated and/or contributed to the
regulatory mechanism responsible for
optimizing ovarian function and
secretion of the quantity of estrogen –
in some cases– well above the 30pg/ ml
considered as desired minimum.
Irrespective of the sequence in which
Placebo was introduced during the four
month trial, two months of Maca-GO
application magnified the therapeutic
effects of the treatment.
Meissner et
al., 2006c
(Trial II)
66
double-blind,
randomised,
placebo-
controlled,
cross-over,
out-patient
study
Hormone-Balancing
Effect of Pre-
Gelatinized Organic
Maca (L. peruvianum
Chacon): (III) Clinical
responses of early
postmenopausal
women to Maca in
double blind,
randomized,
Placebo-controlled,
crossover
configuration,
outpatient study
22 healthy early post-
menopausal Caucasian
women aged 49-58
years old with blood
Estrogen (E2<40 pg/ml)
and Follicle Stimulating
Hormone (FSH>30
IU/ml) at admission (A)
(11 participants per
group - Maca (M) and
Placebo (P) over 4
months A-P-P-M-M and
A-M-M-P-P (2 X 2) )
Two 500mg
vegetable hard
capsules twice a
day (total 2g/day)
cross-over
study:
placebo
2g/day
Hormone levels of: E2, PGR,
LH, FSH, ACTH, Cortisol (C),
TSH, T4, T3, TGR, CHOL,
HDL, LDL, blood pressure,
body weight, serum mineral
content, Menopausal
symptoms and associated
overall discomfort
experienced measured
through Greene's Score
(MGS) and Menopausal
Kupperman's Index (MKI)
Maca-Go significantly decreased BMI
after 4 month in A-P-P-M-M
treatment group. No significant
difference in decreasing systolic or
diastolic blood pressures. No
significant differences in FSH and PGR
levels in either treatment sequence
but Maca-Go significantly increased
E2 levels while decreasing
simultaneously LH levels relative to
placebo. Changes due to placebo
introduced prior to maca treatment
were more pronounced than those
with placebo after maca treatment
suggesting that treatment with Maca-
Go had residual effect. No statistically
significant difference in
concentrations of the TSH, T4 but T3
and ACTH and Cortisol showed
significant reduction. No statistically
significant change in plasma
cholesterol, HDL and triglycerides
though a significant reduction in LDL
level was noted with Maca-Go
treatment. In A-M-M-P-P group there
was a significant increase in serum
Iron and calcium levels. Both
treatment sequence showed a
significant reduction in GS and KMI
scores relative to placebo. The
positive effect with placebo observed
after 1 month in the A-P-P-M-M
treatment sequence decreased after
the second month placebo treatment,
indicating that Maca-GO is indeed
responsible for observed
improvement in GS and KMI scores.
Effect of maca-GO relative to placebo
was more noticeable with KMI score
than GS score.
in addition to a significant increase in
E2, lowered LH, T3, CT, ACTH and
steady FSH and PRG levels, there was a
highly significantly reduction in BMI
and both frequency and intensity of
menopausal symptoms such as hot
flushes, profound perspiration (night
sweating), as well as reduced
depression, irritability, difficulty in
falling asleep and other as
demonstrated by the KMI and GMS,
which may indicate similar effect as the
one induced by the HRT treatment.
Maca-GO applied to early-
postmenopausal women (i) acted as a
toner of hormonal processes along the
Hypothalamus-Pituitary-Ovarian axis,
(ii) balanced hormone levels and (iii)
relieved symptoms of menopausal
discomfort, (hot flushes and night
sweating in particular), thus, (iv)
exhibited a distinctive function peculiar
to adaptogen, providing an alternative
non-hormonal plant option to reduce
dependence on hormone therapy
programs (HRT ). Length of treatment
with maca influences the positive effect
observed with two months treatment
magnifying the effects relative to one
month treatment.
Meissner et
al., 2006d
(Trial III) (A)
Hormone
levels
67
double-blind,
randomised,
placebo-
controlled,
out-patient
study
Hormone-Balancing
Effect of Pre-
Gelatinized Organic
Maca (L. peruvianum
Chacon): (III) Clinical
responses of early
postmenopausal
women to Maca in
double blind,
randomized,
Placebo-controlled,
crossover
configuration,
outpatient study
12 healthy early post-
menopausal Caucasian
women aged 49-58
years old with blood
Estrogen (E2<40 pg/ml)
and Follicle Stimulating
Hormone (FSH>30
IU/ml) at admission (6
per group M and P both
assessed after 4
months)
Two 500mg
vegetable hard
capsules twice a
day (total 2g/day)
2g/day
placebo
bone density markers: bone
density scan
Bone density measures were found to
increase with maca-Go treatment
with an associated decrease in serum
FSH( 55%) and increase in E2 (135%)
levels but not with placebo.
see above Meissner et
al., 2006d
(Trial III) (B)
Pilot Bone
Density
Observation
randomised,
double-blind,
placebo-
controlled,
crossover trial
Beneficial effects of
L. meyenii (Maca) on
psychological
symptoms and
measures of sexual
dysfunction in
postmenopausal
women are not
related to estrogen
or androgen content
14 postmenopausal
women aged 50-60
years old who were
amenorrheic for 12
months or more and
reported experiencing
fatigue, lack of energy,
difficulty in sleeping,
and hot flushes of
moderate severity and
not taking any
treatment
3.5g/day of maca
powder provided
in sachets
consumed in
breakfast cereal,
milkshakes or
soup for 6 weeks
Cross-over
study;
placebo of
refined
white rice
flour for 6
weeks
Estradiol, Follicle
Stimulating Hormone,
Luteinising Hormone, sex-
hormone biding globulin,
Greene's Climacteric Scale
Body weight and body mass index did
not change significantly during the
study. There was no difference
between groups for serum
parameters but test reported as not
sensitive enough. Greene's Climacteric
test showed significant reduction of
scores for psychological symptoms of
anxiety, depression and sexual
dysfunction. Total score reduction of
18% relative to baseline and 17.3%
relative to placebo treatment. No
significant changes between somatic
and vasomotor score.
The absence of change in serum
hormone levels, indicate that maca has
no estrogenic effect unlike Meissner at
al., 2006. In-vitro assay also confirms
absence of physiologically significant
estrogenic activity in maca
Brooks et
al., 2008
68
randomised,
double-blind,
placebo-
controlled,
crossover trial
The effect of L.
meyenii (MACA) on
physiological and
psychological
parameters in
postmenopausal
Hong Kong Chinese
women.
31 healthy Hong Kong
Chinese
postmenopausal
women.
3.3g/day of maca
powder
encapsulated for
6 weeks and
placebo for 6
weeks and vice-
versa (total 12
weeks)
placebo for
6 weeks
Blood sampled at baseline,
after 6 weeks and 12 weeks:
Estradiol, FSH, Sex hormone
binding globulin, thyroid
stimulating hormone, lipid
profile and plasma
cytokines, Greene
Climacteric scale, SF-36
Version 2 scale, Women's
Health Questionnaire, Utian
Quality of Life Scale.
Significant decrease in systolic and
diastolic pressure while no differences
were found in serum concentrations
of estradiol, FSH, LH, TSH, SHBG,
glucose, lipid profile and plasma
cytokines (IL-2, IL-4, IL-5, IL-10, IL-12
(p70), IL-13, GM-CSF, IFN-g and TNF-a)
between baseline, Maca treatment
and placebo. GCS showed a significant
reduction in both maca and placebo.
Women's Health Questionnaire Scale
showed significant reduction in
anxiety scores in both Maca and
placebo (p=0.01), while significant
reduction in depression score was
seen only with Maca administration
(p=0.04). Utian Quality of Life Scale
showed no significant increase in QoL
in the emotional and sexual domain.
The Quality of Life SF36-v2 Scale
revealed significantly increased scores
in general (p=0.02) and mental health
(p=0.03) in both Maca and placebo
groups, while placebo significantly
increased the scores (p<0.05) in social
functioning.
Maca does not exert estrogenic action,
however, despite its high placebo
effect it appears to decrease blood
pressure, reduces psychological
symptoms including anxiety,
depression and improves general
health and well being in Chinese
postmenopausal women.
Stojanovska
et al., 2011
69
randomised,
double-blind,
placebo-
controlled,
crossover trial
Maca reduces blood
pressure and
depression, in a
pilot study in
postmenopausal
women
29 postmenopausal
Hong Kong Chinese
women aged 46-59
years.
3.3g/day maca
capsules (seven
426mg maca
capsules; 4 at
breakfast and 3
at dinner) over 6
weeks (15
women started
maca treatment
first)
placebo
(refined
white rice
flour) over 6
weeks (14
women
started
placebo
treatment
first)
Estradiol, Follicle
Stimulating Hormone (FSH),
sex-hormone biding globulin
(SHBG), Thyroid Stimulating
Hormone (TSH), full lipid
profiles, glucose and serum
cytokines, Greene's
Climacteric Scale (GCS), SF-
36 Version 2, Women's
Health Questionnaire
(WHQ), Utian Quality of Life
Scales (UQLS)
No difference between maca treated
group and placebo group in serum
estradiol, FSH, SHBG, TSH (granted
test used not sensitive enough), lipid
profiles, glucose and serum cytokines.
With GCS, Anxiety and depression
subgroup score showed significant
reduction relative to both baseline
and placebo. Somatic symptoms were
also decreased significantly by 27%
relative to baseline. A significant
positive placebo effect was present on
the overall score. With SF-36 V2, no
significant difference was observed
between maca and placebo groups for
mental and overall well-being. No
difference in physical functioning,
vitality, emotional well-being, body
pain. With WHQ study, both placebo
and maca showed and improvement
in fear/anxiety. Placebo even
improved sleeping patterns and
somatic symptoms. GCS and WHQ
showed a non-significant
improvement in sexual function. UQLS
study showed no statistical difference
in any domains of occupational
health, emotional health and sexual
quality of life.
Maca did not show estrogenic effect in
Chinese Hong Kong women, nor was
there an effect on immunological
function as tested through biomarkers
and cytokines, BMI, blood glucose and
triglycerides, HDL, LDL and cholesterol.
The decreasei n diastolic blood
pressure with maca treatment suggests
a potential cardiovascular effect of
maca. Placebo effect was e high. All the
tests did not have the same level of
sensitivity.
Stojanovska
et al., 2015
70
double-blind,
placebo-
controlled
clinical trial
A Double-Blind
Placebo-Controlled
Trial of
Maca Root as
Treatment for
Antidepressant-
Induced
Sexual Dysfunction in
Women
42 female outpatients
(aged 18-65; mean age
of 41.5 ± 12.5 years)
with SSRI/SNRI-induced
sexual dysfunction with
remitted depression (30
premenopausal and 12
post-menopausal);
patients should have
been taking SSRI,
venlafaxine, or a
tri/hetero cyclic
antidepressant for the
treatment of depression
at a stable dose for at
least 4 weeks.
1500mg maca
root twice daily
placebo
twice daily
Arizona Sexual Experience
Scale (ASEX), Massachusetts
General Hospital Sexual
Function Questionnaire
(MGH-SFQ), Clinical Global
Impression-Severity (CGI-S)
and Clinical Global
Impression-Improvement
(CGI-I) scales; For anxiety
and depression, 28 item
HAM-D, 14 item HAM-A and
Keller's Symptoms
Questionnaire; serum assay
of estradiol, progesterone,
prolactin and testosterone
ITT analysis. Remission rate for
attainment of ASEX score < or= 8 and
MGH-SFQ score < or = 12, were higher
for the maca group than the placebo
group. Higher remission rates were
observed in the postmenopausal
group with maca than placebo. Maca
improved orgasm in post-menopausal
women but not in premenopausal
women where only arousal was
improved. Change in testosterone
from baseline to endpoint in placebo
group did not correlate significantly
but correlated significantly in maca
group. (This indicates possible
androgenic action of maca). Maca was
well-tolerated overall but Liver
Function Tests were not performed.
Authors postulate that changes in FSH
and LH via negative feedback loop
result in an increase production of
androgens that could explain the
improvement in sexual functioning.
However, it is stated that the assays
employed to detect testosterone levels
in women may not have been sensitive
enough and that self-reporting of
orgasm is subjective. Maca has more
positive effect in menopausal women
than premenopausal women with AISD.
Dording et
al., 2015
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Num
-ber Compound Structure
Source Refer-
ence
ALKALOIDS
1
Lepidiline A.1,3-
dibenzyl-4,5-
dimethylimidazoli
um chloride
Concentrated
lipid extract of
maca root
Cui et
al.,
2003
2
Lepidiline B. 1,3-
dibenzyl-2,4,5-
trimethylimidazoli
um chloride
Concentrated
lipid extract of
maca root
Cui et
al.,
2003
3
Lepidiline C. 1-
benzyl-3-(3-
methoxybenzyl)-
4,5-
dimethylimidazoli
um chloride
Ethanolic 95% of
dried maca root
extract
Jin et
al.,2016
4
Lepidiline D. 1-
benzyl-3-(3-
methoxybenzyl)-
2,4,5-
trimethylimidazoli
um chloride
Ethanolic 95%
dried maca root
extract
Jin et
al.,2016
(Supplementary data) Appendix S1: Secondary metabolites found in Maca2
5
Macaridine: 3-
Benzyl-1,2-
dihydro-N-
hydroxypyridine-
4-carbaldehyde
petroleum ether
extract of
tubers of
L.meyenii
Muham
mad et
al.,
2002
MACAHYDANTOINS
1
3-benzyl-2-thioxo-
1,3-
diazabicyclo[3.3.1
]nonan-4-one
(Macahydantoin
A)
No mention of
extract. L.
meyenii from
regions of
Lijiang and Dali
in China
Yu et
al.,
2017a
2
5-hydroxy-3-(3-
methoxybenzyl)-
2-thioxo-1,3-
diazabicyclo[3.3.1
]nonan-4-one
(Macahydantoin
B)
No mention of
extract. L.
meyeniifrom
regions of
Lijiang and Dali
in China
Yu et
al.,
2017a
MACATHIOHYDANTOINS
1
2-(3-
hydroxybenzyl)-3-
thioxohexahydro-
1H-pyrrolo[1,2-
c]imidazol-1-one
(Macathiohydant
oin B)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
extracted with
95% methanol
Yu et
al.,
2017b
(Supplementary data) Appendix S1: Secondary metabolites found in Maca3
2
2-(3-
methoxybenzyl)-
3-
thioxohexahydro-
1H-pyrrolo[1,2-
c]imidazol-1-one
(Macathiohydant
oin C)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
extracted with
95% methanol
Yu et
al.,
2017b
3
2-benzyl-7a-
hydroxy-3-
thioxohexahydro-
1H-pyrrolo[1,2-
c]imidazol-1-one
(Macathiohydant
oin D)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
extracted with
95% methanol
Yu et
al.,
2017b
4
7a-hydroxy-2-(3-
hydroxybenzyl)-3-
thioxohexahydro-
1H-pyrrolo[1,2-
c]imidazol-1-one
(Macathiohydant
oin E)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
extracted with
95% methanol
Yu et
al.,
2017b
5
2-benzyl-7a-
methoxy-3-
thioxohexahydro-
1H-pyrrolo[1,2-
c]imidazol-1-one
(Macathiohydant
oin F)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
Yu et
al.,
2017b
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extracted with
95% methanol
6
7a-hydroxy-2-(3-
hydroxybenzyl)-3-
thioxohexahydro-
1H-pyrrolo[1,2-
c]imidazol-1-one
(Macathiohydant
oin G)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
extracted with
95% methanol
Yu et
al.,
2017b
7
1-benzyl-3-(3-
methoxybenzyl)-
5-methyl-2-
thioxoimidazolidi
n-4-one
(Macathiohydant
oin H)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
extracted with
95% methanol
Yu et
al.,
2017b
8
3-benzyl-1-(3-
methoxybenzyl)-
5-methyl-2-
thioxoimidazolidi
n-4-one
(Macahtiohydant
oin I)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
extracted with
95% methanol
Yu et
al.,
2017b
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9
1,3-dibenzyl-5-
hydroxy-5-
methyl-2-
thioxoimidazolidi
n-4-one
(Macahydantoin
J)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
extracted with
95% methanol
Yu et
al.,
2017b
10
3-benzyl-5-
hydroxy-1-(3-
methoxybenzyl)-
5-methyl-2-
thioxoimidazolidi
n-4-one
(Macathiohydant
oin K)
Rhizomes of
L.meyeniicollect
ed from Li
Jiang of Yunnan
Province of
China in 2014.
Extract: air-
dried powdered
maca stem
extracted with
95% methanol
Yu et
al.,
2017b
MEYENIINS
1
(7aR)-6-
(benzo[d][1,3]dio
xol-5-ylmethyl)-3-
methyl-5-
thioxotetrahydro-
3H,7H-
imidazo[1,5-
c]thiazol-7-one
(Meyeniin A)
L. meyenii were
collected from
Lijiang,
Yunnan
province, China,
in September
2014. Extract:
air-dried tubers
extractedeat
80% aqueous
acetone at room
temperature
Zhou et
al.,
2017
N N
S
O HO Me
N N
S
O HO Me
O
Me
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2
(7aR)-6-benzyl-3-
methyl-5-
thioxotetrahydro-
3H,7H-
imidazo[1,5-
c]thiazol-7-one
(Meyeniin B)
L. meyenii were
collected from
Lijiang,
Yunnan
province, China,
in September
2014. Extract:
air-dried tubers
extractedeat
80% aqueous
acetone at room
temperature
Zhou et
al.,
2017
3
(7aR)-6-(3-
methoxybenzyl)-
3-methyl-5-
thioxotetrahydro-
3H,7H-
imidazo[1,5-
c]thiazol-7-one
(meyeniin C)
L. meyenii were
collected from
Lijiang,
Yunnan
province, China,
in September
2014. Extract:
air-dried tubers
extractedeat
80% aqueous
acetone at room
temperature
Zhou et
al.,
2017
MACA ALKAMIDES - MACAMIDES
1
N-benzyl-5-oxo-
6E,8E-
octadecadienami
de
petroleum ether
extract of dried
ground tubers
of L.meyenii
Muham
mad et
al.,
2002
2
N-
benzylhexadaeca
namide (N-benzyl
palmitamide)
petroleum ether
extract of
tubers of
L.meyenii
Muham
mad et
al.,
2002;
McCollo
m et al.,
2005
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3
(6E,8E)-5-
oxooctadeca-6,8-
dienoic acid
(acyclic keto acid)
petroleum ether
extract of
tubers of
L.meyenii
Muham
mad et
al.,
2002
4
N-benzyl-9-oxo-
12Z-
octadecenamide
95% EtOH
extract of dried
ground tuber
Zhao et
al.,
2005
5
N-benzyl-9-oxo-
12Z,15Z-
octadecadienami
de
95% EtOH
extract of dried
ground tuber
Zhao et
al.,
2005
6
N-benzyl-13-oxo-
9E,11E-
octadecadienami
de
95% EtOH
extract of dried
ground tuber
Zhao et
al.,
2005
7
N-benzyl-15Z-
tetracosenamide
[n-
benzylInervonami
de]
95% EtOH
extract of dried
ground tuber
Zhao et
al.,
2005
8
N-(m-
methoxybenzyl)h
exadecanamide
95% EtOH
extract of dried
ground tuber
Zhao et
al.,
2005
9 N-benzyloleamide
petroleum ether
extract of dried
ground tubers
of L.meyenii
McCollo
m et al.,
2005
10
N-(3-
methoxybenzyl)ol
eamide
petroleum ether
extract of dried
ground tubers
of L.meyenii
McCollo
m et al.,
2005
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11
(9Z,12Z)-N-
benzyloctadeca-
9,12-dienamide
[n-
benzyllinoleamide
]
petroleum ether
extract of dried
ground tubers
of L.meyenii
McCollo
m et al.,
2005
12
(9Z,12Z)-N-(3-
methoxybenzyl)oc
tadeca-9,12-
dienamide
petroleum ether
extract of dried
ground tubers
of L.meyenii
McCollo
m et al.,
2005
13
(9Z,12Z,15Z)-N-
benzyloctadeca-
9,12,15-
trienamide [n-
benzyllinolenamid
e]
petroleum ether
extract of dried
ground tubers
of L.meyenii
McCollo
m et al.,
2005
14
(9Z,12Z,15Z)-N-(3-
methoxybenzyl)oc
tadeca-9,12,15-
trienamide
petroleum ether
extract of dried
ground tubers
of L.meyenii
McCollo
m et al.,
2005
15
N-
benzylstearamide
petroleum ether
extract of dried
ground tubers
of L.meyenii
McCollo
m et al.,
2005
16
N-
benzylheptadecan
amide
petroleum ether
extract of dried
ground tubers
of L.meyenii
McCollo
m et al.,
2005
17
N-
benzylpentadecan
amide
petroleum ether
extract of dried
ground tubers
of L.meyenii
McCollo
m et al.,
2005
18
N-(3,4-
dimethoxybenzyl)
-hexadecanamide
hexane extract
of dried ground
tubers of
L.Meyenii
Chain et
al.,
2014
(Supplementary data) Appendix S1: Secondary metabolites found in Maca9
19
N-
benzyltetracosana
mide
hexane extract
of dried ground
tubers of
L.Meyenii
Chain et
al.,
2014
20
N-benzyl-3-
hydroxy-
benzeneamide
waterextrract of
L.Meyenii roots
cultivated in
Jilin, China
Zheng
et al.,
2014
21
N-benzyl
octanamide
extraction from
L.meyenii root
using aqueous
solvent
comprising of
90% by vol. or
more water
Zheng
et al.,
2003
US
Patent.
US
6,552,2
06 B1
22
N-benZyl-16(R,S)-
hydroXy-9-oXo-
10E,12E,14E-
octadecatrieneam
ide
extraction from
L.meyenii root
using aqueous
solvent
comprising of
90% by vol. or
more water
Zheng
et al.,
2003
US
Patent.
US
6,552,2
06 B2
23
N-benzyl-9,16-
dioxo-
10E,12E,14E-
octadecatrieneam
ide
extraction from
L.meyenii root
using aqueous
solvent
comprising of
90% by vol. or
more water
Zheng
et al.,
2003
US
Patent.
US
6,552,2
06 B3
Glucosinolates
1
benzylglucosinola
te
Methanol
extract of dry
maca tubers;
70% methanol
extract of fresh
hypocotyl, fresh
leaf, fresh seed,
sprout, dry
hypocotyl, flour,
Dini et
al.,
2002, Li
et al.,
2001;
Piacent
e et al.,
2002
O
H
N
(Supplementary data) Appendix S1: Secondary metabolites found in Maca10
capsule, pill and
mayonnaise.
2
m-
methoxybenzyl-
glucosinolate (m-
methoxy-
glucotropaeolin)
Methanol
extract of dry
maca tubers
Dini et
al.,
2002;
Piacent
eelat.,
2002)
3
5-
methylsulfinylpen
tyl glucosinolate
(glucoalyssin)
70% methanol
extract of fresh
maca hypocotyl,
leaf, seed,
sprout, dry
maca hypocotyl,
flour, capsule,
pill and
mayonnaise
Li et al.,
2001
4
p-
hydroxybenzylglu
cosinolate
(glucosinalbin)
70% methanol
extract of fresh
maca hypocotyl,
leaf, seed,
sprout, dry
maca hypocotyl,
flour, capsule,
pill and
mayonnaise
Li et al.,
2001
(Supplementary data) Appendix S1: Secondary metabolites found in Maca11
5
m-
hydroxybenzylglu
cosinolate
70% methanol
extract of fresh
maca hypocotyl,
leaf, seed
Li et al.,
2001
6
4-pentenyl
glucosinolate
(glucobrassicanap
in)
70% methanol
extract of fresh
maca hypocotyl
and leaf
Li et al.,
2001
7
Indolyl-3-methyl
glucosinolate
(glucobrassicin)
70% methanol
extract of fresh
maca hypocotyl,
fresh leaf and
dry hypocotyl
Li et al.,
2001
(Supplementary data) Appendix S1: Secondary metabolites found in Maca12
8
4-methoxyindolyl-
3-methyl
glucosinolate (4-
methoxyglucobra
ssicin)
70% methanol
extract of fresh
hypocot, fresh
leaf, seed and
capsule
Li et al.,
2001
9
p-
methoxybenzylglu
cosinolate
(glucolimnanthin)
70% methanol
extract of fresh
hypocotyl, fresh
leaf, sprout, dry
hypocotyl, flour,
capsule, pill,
mayonnaise
Li et al.,
2001
Other compounds
1
Tetrahydromethyl
-b-carboline
Methanol
extract of dry
maca tubers
Piancen
te et al.,
2002
